Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

CURRICULUM VITAE

Kathryn Eve Flynn PhD
Vice Chair, Professor
Department of Medicine
Division of Hematology and Oncology - Medicine
Senior Scientific Director for Patient-Reported Outcomes
Center for International Blood & Marrow Transplant Research

OFFICE ADDRESS:
Clinical Cancer Center
9200 W Wisconsin Ave
Milwaukee, WI 53226
Phone: 414-805-8189
Email: kflynn@mcw.edu

EDUCATION:
09/1996 - 06/1999 B.A., Sociology, University of Minnesota, Twin Cities, MN
09/2000 - 05/2003 M.S. (Thesis: “A Life Course Model of Breastfeeding Behavior”), University of Wisconsin, Madison, WI
01/2002 - 05/2005 Ph.D. in Population Health, Dissertation: “Healthcare Decision Making in Older Adults”, University of Wisconsin, Madison, WI

POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS:
09/2005 - 08/2006 Postdoctoral Fellowship, Patient-reported outcomes, Duke Clinical Research Institute, Durham, NC 27715
09/2017 - 05/2018 Medical College of Wisconsin’s Leadership Academy, University of Wisconsin – Milwaukee Lubar School of Business

FACULTY APPOINTMENTS:
09/2006 - 09/2012 Assistant Professor, Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC 27715
10/2012 - 06/2018 Adjunct Assistant Professor, Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC 27715
10/2012 - 06/30/2014 Assistant Professor, Medicine, Graduate School of Biomedical Sciences, Medical College of Wisconsin, Milwaukee, WI 53226
07/01/2014 - 07/30/2020 Associate Professor, Medicine, Graduate School of Biomedical Sciences, Medical College of Wisconsin, Milwaukee, WI 53226
07/2018 - Present Adjunct Faculty, Population Health Sciences, Duke University School of Medicine, Durham, NC 27715
07/01/2020 - Present Professor, Medicine, Medical College of Wisconsin, Milwaukee, WI 53226

RESEARCH ADMINISTRATIVE APPOINTMENTS:
10/2015 - 10/2017 Associate Director, Center for Patient Care and Outcomes Research, Medical College of Wisconsin
10/2017 - Present Senior Scientific Director for patient Reported Outcomes, Center for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin
03/2024 - Present Vice Chair for Research, Medicine, Medical College of Wisconsin

AWARDS AND HONORS:
1996 Employer's Health Insurance Scholarship
1996 - 1998 Gopher State Scholarship
1999 Excellence in Teaching Award, UMN-Twin Cities, Dept. of Sociology
2004 Vilas Travel Fellowship, Graduate Student Collaborative, UW-Madison
2006 Most Outstanding Abstract Award, AcademyHealth Annual Research Meeting
2011 Duke Translational Medicine Institute Research Career Day Best Abstract Award, Duke Translational Medicine Institute
2014 Best Abstract Prize, World Meeting on Sexual Medicine
2016 Daniel McCarty Award for Research Excellence, Medical College of Wisconsin Department of Excellence
2019 Best Poster Award, American Urological Association
2020 Best Poster Award, American Urological Association
2022 Outstanding Graduate School Educator, Medical College of Wisconsin

MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES:
2002 - 2012 AcademyHealth (Member)
2003 - 2004 International Shared Decision Making (Member)
2005 - 2012 Duke Clinical Research Institute (Member)
2005 - 2006 Society for Medical Decision Making (Member)
2007 - 2012 Duke Cancer Institute (Associate Member)
2010 - Present International Society for Quality of Life Research (Member)
2010 - 2012 American Psycho Oncology Society (Member)
2010 - 2012 Duke University Program in the Study of Sexualities (Affiliate)
2012 - Present International Society for Sexual Medicine (Member)
2012 - Present Medical College of Wisconsin Cancer Center (Member)
2012 - 2017 Medical College of Wisconsin Center for Patient Care and Outcomes Research (Member)
2012 - Present Scientific Network on Female Sexual Health and Cancer (Member)
2015 - Present PROMIS Health Organization (Member)
2017 - Present Medical College of Wisconsin Center for International Blood and Marrow Transplant Research (Member)

EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS:
Journal Review
2006 American Heart Journal; Medical Care; Patient Education & Counseling; Social Science & Medicine
2007 Health Expectations; Health Psychology; Social Science & Medicine
2008 American Heart Journal; Evaluation and Program Planning; Health Expectations; Social Science & Medicine
2009 Cochrane Database of Systematic Reviews Cochrane Heart Group; Clinical Trials; Health Expectations; Medical Decision Making
2010 American Heart Journal; Circulation: Cardiovascular Quality and Outcomes JAMA; Journal of the American College of Cardiology Supportive Care in Cancer
2011 American Heart Journal; Psycho-Oncology
2012 Psycho-Oncology; Women’s Health Issues
2013 American Journal of Psychology; Journal of the American College of Cardiology – Heart Failure; Patient Education & Counseling; Quality of Life Research; Women’s Health Issues
2014 Journal of Sexual Medicine; Translational Andrology and Urology (TAU)
2015 Circulation: Heart Failure; Clinical Trials; Female Pelvic Medicine & Reconstructive Surgery; Journal of Alternative and Complimentary Medicine; Journal of Sexual Medicine; Psycho-Oncology
2016 BMC Health Services Research; Journal of Sexual Medicine; Quality of Life Research; Women’s Health Issues
2017 Clinical Trials; Journal of Sexual Medicine; Supportive Care in Cancer
2018 Journal of Sexual Medicine; Journal of Patient-Reported Outcomes; PLOS One; Qualitative Psychology; Supportive Care in Cancer; Women’s Health
2019 Addiction; Circulation: Cardiovascular Quality and Outcomes; Health and Quality of Life Outcomes; Journal of Sexual Medicine; Reproductive Health; The Lancet Haematology;
2020 Clinical Trials; Journal of General Internal Medicine; Quality of Life Research; Journal of Sexual Medicine; Patient Education & Counseling
2021 Circulation: Cardiovascular Quality and Outcomes; Journal of Patient-Reported Outcomes; Supportive Care in Cancer
2022 Alcohol; American Journal of Obstetrics and Gynecology; BMC Health Services Research; Bone Marrow Transplantation
2022 Journal of General Internal Medicine; Journal of Patient-Reported Outcomes; Supportive Care in Cancer
2023 Patient-Centered Outcomes Research Institute (PCORI) Research Reports; PLOS One; Social Science & Medicine; The Lancet Haematology
2023 BMC Cancer; BMC Gastroenterology; BMC Health Services Research; Disability and Rehabilitation; Journal of Patient-Reported Outcomes;
Ad-Hoc Reviewer
2017 - Present International Society of Quality of Life annual conference
2020 - 2022 Collaborating for the Advancement of Interdisciplinary Research in Benign Urology meeting
2021 Scientific Network on Female Sexual Health and Cancer conference

LOCAL/REGIONAL APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
2006 - 2009 Member, Sexual Function Domain Committee, NIH PROMIS
2006 - 2009 Member, Sleep/Wake Function Domain Committee, NIH PROMIS
2012 - 2014 Member, MCW Cancer Center’s Supportive Oncology Initiative, Medical College of Wisconsin
2013 - 2014 Member, Research Strategy Population Health Work Group, Medical College of Wisconsin’
2014 - 2020 Reviewer, Cancer Center Seed Grant Review Committee, Medical College of Wisconsin
2016 - 2017 Member, Faculty Research Council, Medical College of Wisconsin
2016 - Present Reviewer, ACS-IRG Grant Review Committee, Medical College of Wisconsin
2016 - 2019 Member, Cancer Center Community Engagement Faculty Recruitment Committee, Medical College of Wisconsin
2016 - 2017 Reviewer, Community Engaged Research Seed Grant Review Committee, Medical College of Wisconsin
2016 - 2022 Member, Department of Medicine Research Retreat Committee, Medical College of Wisconsin
2017 - 2022 Member, Department of Medicine Research Committee, Medical College of Wisconsin
2018 - Present Reviewer, Advancing a Healthier Wisconsin Research and Education Program Responsive Component, Medical College of Wisconsin
2018 - 2020 Member, Center for International Blood and Marrow Transplant Research (CIBMTR) Late Effects Task Force, Medical College of Wisconsin
2020 - Present Reviewer, Cancer Center Pilot Grant Program, Medical College of Wisconsin
2020 - 2022 Co-Chair, Department of Medicine Research Committee, Medical College of Wisconsin
2021 - 2022 Member, Cancer Center Population Science Faculty Recruitment Committee, Medical College of Wisconsin
2022 - 2023 Member, Cancer Center Space Committee, Medical College of Wisconsin
2022 - 2024 Member, Director of Clinical and Community Outcomes Recruitment Committee, Children’s Research Institute
2022 - Present Member, Graduate School Rank Committee, Medical College of Wisconsin

NATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
2009 - 2015 Chair, Sexual Function Domain Committee, NIH PROMIS
2012 Member, Special Emphasis Panel: Ancillary Domain Validation Patient-Reported Outcomes Measurement Information System (PROMIS®) Studies (R01, RFA-AR-12-007), NIH
2013 - 2014 Ad-hoc Member, Scientific Review Group: Health Care Research Training (HCRT), AHRQ
2014 - Present Special Government Employee, Food and Drug Administration Center for Drug Evaluation and Research (FDA/CDER)
2014 Voting Member, Bone, Reproductive and Urologic Drugs Advisory Committee, review of flibanserin, FDA/CDER
2014 Member, Special Emphasis Panel: Researcher Training and Workforce Development in Methods and Standards for Conducting Patient-Centered Outcomes Research Studies (RFA HS 14-004), AHRQ
2014 - 2015 Ad-hoc Member, Scientific Review Group: Health Services Organization and Delivery (HSOD), NIH
2016 Reviewer, Special Emphasis Panel/Scientific Review Group: NIH Director’s Early Independence Award (D5, ZRG1 RPHB-W 53 R), NIH
2016 - 2020 Standing Member, Scientific Review Group: Health Services Organization and Delivery (HSOD), NIH
2017 - 2020 Co-Chair, International Society for Quality of Life Research, Quality of Life in Clinical Practice Special Interest Group
2018 Member, Special Emphasis Panel: NCI Moonshot Initiative on Cancer Symptom Management (UM1, RFA-CA-17-042), NCI
2018 Voting Member, Psychopharmacologic Drugs Advisory Committee, review of buprenorphine-samidorphan, FDA/CDER
2021 - 2024 Director-at-large, International Society for Quality of Life Research (ISOQOL) Board of Directors
2024 - 2025 Chair, International Society for Quality of Life Research (ISOQOL) 2025 Annual Conference

RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS:
Active
Peer Review
Title:
Advancing the Measurement and Classification of Lower Urinary Tract Dysfunction (LURN 2)
Source:
NIDDK, U01 DK 097780
Role & Effort:
Co-investigator, Principal Investigator on MCW subcontract
PI:
Amundson and Jelovsek
Dates:
09/01/2019 - 08/31/2024
Direct Funds:
$359,405 (To better understand the nature of the symptoms that characterize lower urinary tract dysfunction in men and women and to develop and test measurement tools to describe lower urinary tract symptoms in a 6-site collaborative network.)
  
Title:
Bridging Community-based Continence Promotion and Primary Care
Source:
AHRQ U18 HS028738
Role & Effort:
Principal Investigator
PI:
Brown, Neuner, Flynn
Dates:
02/01/2022 - 01/31/2025
Direct Funds:
$2,931,870 (Effective non-surgical treatments are available for urinary incontinence but often do not reach patients. The WI-INTUIT intervention helps primary care clinics incorporate screening and treatment of urinary incontinence. We will compare two implementation strategies through a type 3 hybrid cluster randomized trial of primary care practices. )
  
Title:
Gestational Diabetes and Pharmacotherapy (GAP) – A Randomized Controlled Trial Investigating Timing of Pharmacotherapy Initiation for Patients with Gestational Diabetes
Source:
NICHD R01 HD108194
Role & Effort:
Co-Investigator
PI:
Palatnik
Dates:
04/01/2022 - 03/31/2027
Direct Funds:
$2,520,892 (The GAP study is a randomized controlled trial to evaluate the timing of pharmacotherapy initiation in Gestational Diabetes (GDM).)
  
Title:
Medical Student Summer Research Training in Aging & Injury
Source:
NIA/NRSA T35-AG076419
Role & Effort:
Research Faculty
PI:
Meurer
Dates:
09/01/2023 - 08/31/2028
Direct Funds:
$513,445 (To train medical students on projects related to aging and NIA priorities through summer research stipends. )
  
Title:
Exploring Age Differences in Patient Reported Cognitive Function Trajectories among Hematopoietic Stem Cell Transplant and Chimeric Antigen Receptor T-cell patients and Linking Two Key Measures
Source:
NIA R21 AG077024
Role & Effort:
Co-investigator
PI:
Cusatis, Rachel
Dates:
09/11/2023 - 08/31/2025
Direct Funds:
$429,000 (The proposed research will produce evidence of construct validity for self-reported cognitive function measures used in a national cellular therapy registry, link scores of two dominant measures of cognitive function, and provide novel description of trajectories of cognitive function among cellular therapy patients. )
  
Non-Peer Review
Title:
HJKC3-0002: Treatment Free Remission After Combination Therapy with Ruxolitinib Plus Tyrosine Kinase Inhibitors in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation
Source:
Incyte Corporation
Role & Effort:
Co-investigator
PI:
Sweet/Pinilla-Ibarz
Dates:
09/01/2019 - 08/31/2029
Direct Funds:
$2,838,805
  
Title:
HJKC3-0003: Treatment Free Remission After Combination Therapy with Asciminib Plus Imatinib Discontinuation
Source:
Novartis
Role & Effort:
Co-investigator
PI:
Mauro
Dates:
2020 - 2025
Direct Funds:
$2,065,723
  
Title:
HJKC3-0004: Asciminib as Initial Therapy For Patients With Chronic Myeloid Leukemia In Chronic Phase
Source:
Novartis
Role & Effort:
Co-investigator
PI:
Cortes
Dates:
2023 - 2030
Direct Funds:
$3,720,298
  
Title:
HJKC3-0007: Real World Outcomes of Patients with CML-CP Treated with Asciminib and Other Tyrosine Kinase Inhibitors
Source:
Novartis
Role & Effort:
Principal Investigator
PI:
Atallah, Flynn, Thompson, Mauro
Dates:
2023 - 2028
Direct Funds:
$1,624,424
  
Prior
Peer Review
Title:
ACTION EQOL Study
Source:
NIH, U01 HL66461
Role & Effort:
Co-investigator
PI:
Schulman
Dates:
09/30/2002 - 12/31/2009
Direct Funds:
$2,602,524 (HF-ACTION was a randomized trial of exercise training versus usual care evaluating all-cause mortality for patients with New York Heart Association Class II-IV congestive heart failure. The Economics and Quality of Life (EQOL) substudy assessed costs (money and resources), and the additional benefits of quality and length of life of the exercise training intervention.)
  
Title:
PhD Training in Population Health & Quality Improvement
Source:
AHRQ, T32 HS000083
Role & Effort:
Trainee
PI:
Fryback
Dates:
09/01/2003 - 12/31/2004
  
Title:
Dynamic Assessment in Multi-Center Trials
Source:
NIH, U01 AR 052186
Role & Effort:
Co-investigator
PI:
Weinfurt
Dates:
09/28/2004 - 09/29/2009
Direct Funds:
$6,721,883 (The goal of the Patient-Reported Outcomes Measurement Information System (PROMIS) Network was to develop a unified approach for assessing PROs using item response theory and computerized adaptive testing (CAT). )
  
Title:
Health Care Decision Making in Older Adults
Source:
AHRQ, R36 HS015544
Role & Effort:
Principal Investigator
PI:
Flynn, Kathryn
Dates:
02/15/2005 - 08/19/2005
Direct Funds:
$30,000 (I examined how patient and provider characteristics and the provider-patient relationship influence both preferences for participation in health care visits and proactive behaviors related to health care decisions for older patients in the Wisconsin Longitudinal Study. )
  
Title:
NIH Clinical Loan Repayment
Source:
NIH Division of Loan Repayment
Role & Effort:
Recipient
PI:
Flynn, Kathryn
Dates:
07/01/2008 - 06/30/2010
Direct Funds:
$9,021 (The NIH Loan Repayment Program is a vital component of our nation's efforts to attract health professionals to careers in clinical research. In exchange for a two-year commitment to a research career, NIH will repay 25% of qualified educational debt per year. )
  
Title:
AHA-PRT Outcomes Research Center Project: Preventing ‘Recurrent Failure’
Source:
American Heart Association, 0875412N
Role & Effort:
Co-investigator
PI:
Hernandez
Dates:
10/01/2008 - 09/30/2012
Direct Funds:
$630,286 ( As part of research training for cardiology fellows, this project sought to understand the early death and readmission after a hospitalization for heart failure and disseminate leading practices or systems of care that are associated with low readmission rates. I advised the team in designing and analyzing a survey of hospital practices administered to 100 hospitals that participate in the AHA’s Get with the Guidelines program.)
  
Title:
Cognitive Aging in Context: Abilities, Literacy, and the Social Environment
Source:
NIA 5P01 AG 021079
Role & Effort:
Principal Investigator on Subcontract
PI:
Hauser
Dates:
07/01/2009 - 06/31/2011
Direct Funds:
$33,558 (To use data from the Wisconsin Longitudinal Study to analyze the causes and consequences of cognitive functioning among the elderly. I led the study aim that addressed the role of cognitive functioning in health care decision-making and health information seeking.)
  
Title:
Clinical Trials Transformation Initiative - Reporting Serious Adverse Events
Source:
FDA, U19 FD003800
Role & Effort:
Co-investigator
PI:
Kramer
Dates:
09/20/2009 - 08/31/2010
  
Title:
Validating and Extending the PROMIS Sexual Function Measure for Clinical Research
Source:
NIH, U01 AR 052186
Role & Effort:
Principal Investigator on Subcontract
PI:
Weinfurt
Dates:
09/30/2009 - 07/31/2015
Direct Funds:
$2,789,872 (The National Institutes of Health (NIH) established the Patient-Reported Outcomes Measurement Information System (PROMIS) Network with the goal of developing a comprehensive, standardized, and efficient means of measuring patient-reported outcomes in persons with chronic diseases. I chaired the Sexual Function Domain Committee to broaden the applicability of the PROMIS Sexual Function and Satisfaction measure to chronic diseases beyond cancer. )
  
Title:
Clinical Trials Transformation Initiative - Use of Central IRBs for Multicenter Clinical Trials
Source:
FDA, U19 FD 003800
Role & Effort:
Co-investigator
PI:
Kramer
Dates:
09/01/2010 - 08/31/2012
Direct Funds:
$271,182 (To identify potential solutions to address barriers to the adoption of central IRBs for multicenter clinical trials. I led the research team in soliciting current perceptions of barriers to the use of central IRBs in multicenter clinical trials and proposed solutions to remove these barriers. We held an expert meeting to review these results and develop a strategy to address the identified barriers.)
  
Title:
Health Care Systems Research Collaboratory - Coordinating Center
Source:
OD, U54 AT 007748
Role & Effort:
Principal Investigator on Subcontract
PI:
Hernandez, Curtis, and Weinfurt
Dates:
09/30/2012 - 08/31/2017
Direct Funds:
$80,791 (To transform the conduct of clinical trials in the US by conducting trials using electronic health records in the context of integrated health systems. I was a member of the Patient Reported Outcomes Core and contributed to the online Living Textbook.)
  
Title:
Advancing the Measurement and Classification of Lower Urinary Tract Dysfunction (LURN 2)
Source:
NIDDK, U01 DK 097780
Role & Effort:
Principal Investigator on MCW subcontract
PI:
Flynn, Amundson and Jelovsek
Dates:
09/30/2012 - 07/31/2019
Direct Funds:
$221,229 (To better understand the nature of the symptoms that characterize lower urinary tract dysfunction in men and women and to develop and test measurement tools to describe lower urinary tract symptoms in a 6-site collaborative network.)
  
Title:
Decision Making by Patients Seeking Care for Fertility Problems
Source:
NICHD, R21 HD 071332
Role & Effort:
Principal Investigator
PI:
Flynn, Kathryn
Dates:
12/01/2012 - 05/31/2016
Direct Funds:
$410,996 (We collected and analyzed longitudinal, qualitative data on the decision-making experiences of patients seeking treatment for infertility, providing much-needed information about how couples negotiate the multifaceted cognitive, financial, and emotional terrain that infertility decision making presents. )
  
Title:
Stopping Tyrosine Kinase Inhibitors in CML Patients
Source:
NCI R01 CA184798
Role & Effort:
Principal Investigator
PI:
Flynn and Atallah
Dates:
09/19/2014 - 08/31/2020
Direct Funds:
$4,137,256 (To discontinue TKI therapy in 172 patients with chronic myeloid leukemia across 14 sites and monitor them closely for 3 years. We will characterize the patient factors associated with CML recurrence and describe patient-reported health status changes after TKI discontinuation to support patient decision making regarding TKI discontinuation. )
  
Title:
Perception and Use of a Patient Care Window to Improve Care and Family Engagement
Source:
AHRQ R21 HS023626
Role & Effort:
Co-investigator
PI:
Asan
Dates:
09/30/2014 - 09/29/2016
Direct Funds:
$300,000 (To evaluate a novel healthcare information technology (HIT) – a large screen patient care monitor with interactive touch screen information display – to improve patient care and family engagement in the pediatric intensive care unit. I oversaw the qualitative data collection and analysis to understand the use (and lack of use) of these monitors from the perspectives of physicians, nurses and other staff, and families of pediatric patients in the ICU.)
  
Title:
Midwest Child Patient Reported Outcomes (M-cPROs) Consortium
Source:
NIAMS, U19 AR069519
Role & Effort:
Principal Investigator on Project 2 with Elizabeth Cox, Co-investigator on Data Management Core
PI:
Panepinto
Dates:
09/30/2015 - 09/29/2019
Direct Funds:
$2,730,837 (To advance the understanding and measurement of child patient reported outcomes (cPROs) in children with chronic disease (sickle cell disease, asthma, and type 1 diabetes) using PROMIS, to allow for widespread use of cPROs in both clinical care and research.)
  
Title:
A Data Resource for Analyzing Blood and Marrow Transplants
Source:
NCI U24 CA076518
Role & Effort:
Co-investigator
PI:
Horowitz, Mary
Dates:
07/01/2018 - 11/30/2021
Direct Funds:
$19,814,194 (To support the Center for International Blood and Marrow Transplant Research (CIBMTR) including daily operating expenses of the CIBMTR Statistical Center and a portion of the cost of reimbursing participating centers for submitting data collection forms. )
  
Title:
Men Moving Forward: A Lifestyle Intervention for African American Prostate Cancer Survivors
Source:
NCI R01 CA229546 (Stolley)
Role & Effort:
Co-Investigator
PI:
Stolley, Melinda
Dates:
07/01/2018 - 06/30/2023
Direct Funds:
$3,217,658 (To evaluate the effects of the Men Moving Forward cognitive-behavioral lifestyle program on body composition, behavior, quality of life, and biological markers of health and tumorgenesis using a randomized design in 200 African American prostate cancer survivors. )
  
Title:
Immuno-Oncology Translation Network (IOTN): Cellular Immunotherapy Data Resource (CIDR)
Source:
NCI U24 CA233032
Role & Effort:
Co-investigator
PI:
Pasquini
Dates:
09/01/2018 - 11/30/2021
Direct Funds:
$8,544,976 (To develop and maintain a high-quality outcomes database and provide strong statistical support to address important issues in cellular therapy for treatment of cancer. The CIBMTR infrastructure will be expanded to capture patient-reported outcomes, to develop and apply novel statistical techniques, and to establish collaboration with other stakeholders in this field. )
  
Title:
Preemie Prep for Parents (P3) Mobile app: Home Antenatal Prematurity Education
Source:
NICHD R21 HD092664
Role & Effort:
Principal Investigator
PI:
Basir and Flynn
Dates:
01/01/2019 - 12/31/2020
Direct Funds:
$346,500 (To evaluate the effects of a multi-media educational tool (P3) on parental knowledge of prematurity and preparedness for decision making in a randomized controlled trial of 110 pregnant women and partners diagnosed with a preterm birth risk factor. )
  
Title:
Bionic breast project: towards restoring breast sensory function in women with mastectomy
Source:
NCI R21 CA226726
Role & Effort:
Consultant
PI:
Lindau and Bensmaia
Dates:
02/01/2019 - 01/31/2021
Direct Funds:
$208,821 (To develop and validate a comprehensive patient-reported measure of breast sensory function for use in women with and without breast cancer, and to apply state-of-the-art psychophysical sensory assays to determine the relative contributions of nerve fibers toward various aspects of breast sensation, as has been done in the glabrous skin of the hand. )
  
Title:
Development and validation of a disease-relevant patient-reported outcome tool in light chain amyloidosis
Source:
NHLBI K23 HL141445 (D’Souza)
Role & Effort:
Primary Mentor
PI:
D'Souza, Anita
Dates:
05/01/2019 - 04/30/2022
Direct Funds:
$597,384 (This is a mentored patient-oriented research career development award, which incorporates didactics, mentoring, and research experience to augment expertise in AL amyloidosis clinical trials and gain a deeper understanding of patient-centered research and patient-reported outcomes. )
  
Title:
Wisconsin Exploratory Center for Interdisciplinary Research in Benign Urology
Source:
NIDDK P20 DK127511
Role & Effort:
Principal Investigator
PI:
Flynn, Kathryn
Dates:
09/15/2020 - 06/30/2023
Direct Funds:
$616,000 (The Wisconsin Exploratory Center will enhance the intellectual infrastructure of the benign genitourinary research community and foster scientific research that advances the field by bringing together members of our local community of scientists already investigating benign genitourinary diseases, recruiting experienced scientists investigating other conditions to apply their expertise and techniques to the study of benign genitourinary diseases, conducting pilot research, and supporting student research experiences and a seminar series. )
  
Title:
Baseline Symptoms and Adherence to Oral Breast Cancer Therapy among Older Women
Source:
NIA R21 AG064875
Role & Effort:
Principal Investigator
PI:
Flynn and Neuner
Dates:
09/15/2020 - 05/31/2023
Direct Funds:
$429,000 (To examine the association of patient-reported distress at breast cancer diagnosis with early discontinuation of adjuvant endocrine therapy using electronic health record data from a cohort of incident postmenopausal hormone receptor positive breast cancer patients as well as to explore the association of patient-reported symptoms at diagnosis with discontinuation of AET. )
  
Title:
Building a Sustainable Intervention to Improve Endocrine Therapy Adherence
Source:
American Cancer Society MBG-20-142-01
Role & Effort:
Co-Investigator
PI:
Neuner
Dates:
03/01/2021 - 02/28/2024
Direct Funds:
$238,000 (To identify Stage I-III hormone positive breast cancer patients at high risk for early adjuvant endocrine therapy discontinuation and collect qualitative feedback to evaluate and refine a pilot intervention to improve adherence.)
  
Title:
Patient-Prioritized Research Agenda for Children and Adults with Kidney Stones
Source:
PCORI EACB-23076
Role & Effort:
Co-investigator
PI:
Ellison and Tasian
Dates:
01/01/2022 - 12/31/2023
Direct Funds:
$249,824 (To develop a patient-centered research agenda focusing on what matters most to patients and their caregivers and create a community of stakeholders to partner in creating and carrying out the agenda.)
  
Non-Peer Review
Title:
Post-doctoral Fellowship in Outcomes Research
Source:
Ortho Biotech
Role & Effort:
Fellow
PI:
Schulman
Dates:
09/01/2005 - 08/31/2006
  
Title:
Role of Injury in Sarcomagenesis
Source:
Duke Cancer Institute
Role & Effort:
Principal Investigator
PI:
Larrier, Flynn, and Kirsch
Dates:
07/01/2011 - 12/31/2012
Direct Funds:
$100,000 (To 1) develop a survey tool to assess injury history in patients with sarcoma and 2) to characterize the nature of injury required for sarcomagenesis in the mouse model system and identify signaling pathways, which are activated in the process.)
  
Title:
Electronic patient-reported intervention to identify and triage distress in cancer patients
Source:
Clinical & Translational Science Institute of Southeast Wisconsin
Role & Effort:
Co-investigator
PI:
Weibe
Dates:
06/01/2013 - 05/31/2014
  
Title:
Enhancing Oncologist-Patient Discussions of Sexual Function
Source:
MCW Cancer Center Population Sciences Research Program Seed Grant
Role & Effort:
Principal Investigator
PI:
Flynn, Kathryn
Dates:
05/01/2016 - 04/30/2018
Direct Funds:
$25,000 (To inform development of patient coaching to improve patient activation for obtaining care for sexual concerns after cancer. )
  
Title:
Decision Support for Couples Seeking Medical Care for Infertility
Source:
MCW PCORP Seed Grant
Role & Effort:
Principal Investigator
PI:
Flynn, Kathryn
Dates:
07/01/2016 - 06/30/2017
Direct Funds:
$10,000 (To develop and pilot-test an infertility treatment decision aid. )
  
Title:
A study of doxycycline organ response, and health-related quality of life in light chain amyloidosis
Source:
MCW Clinical and Translational Science Institute Mentored Career Development Award KL2
Role & Effort:
Primary Mentor
PI:
D'Souza, Anita
Dates:
07/01/2016 - 03/31/2019
Direct Funds:
$255,000 (To compare organ response rates among patients with AL amyloidosis treated with doxycycline versus no doxycycline and explore patient-reported outcomes to understand prognostic impact on outcomes.)
  
Title:
Use of Digital Multimedia to Enhance Prematurity Counseling
Source:
Children’s Research Institute Seed Grant
Role & Effort:
Co-investigator
PI:
Basir
Dates:
01/01/2017 - 12/31/2017
Direct Funds:
$74,999 (To assess the effect of the multimedia prematurity education-aid (P3 tool) on parent knowledge of prematurity and determine whether use of the P3 tool is associated with changes in anxiety among parents. )
  
Title:
Integrating Patient Values into Care
Source:
MCW PCOR Seed Grant
Role & Effort:
Co-investigator
PI:
Crotty
Dates:
03/01/2017 - 02/28/2018
Direct Funds:
$30,000 (To identify facilitators and barriers to use of PatientWisdom information into routine care. )
  
Title:
Avoiding Health Disparities When Collecting Patient Data for Clinical Care and Pragmatic Research
Source:
Advancing a Healthier Wisconsin Responsive Component
Role & Effort:
Principal Investigator 1/1/18-3/31/18, Significant Contributor starting 4/1/18
PI:
Flynn and Crotty
Dates:
01/01/2018 - 12/31/2019
Direct Funds:
$200,000 (To determine the barriers and facilitators to collecting electronic patient contextual data through a consumer health informatics tool (PatientWisdom) and whether adoption and results of use differ by race. This project assesses the impact of the tool on communication, patient experience, and health services utilization.)
  
Title:
National Chronic Myeloid Leukemia Registry
Source:
MCW Cancer Center Multiple Principal Investigator Pilot Grant
Role & Effort:
Principal Investigator
PI:
Atallah and Flynn
Dates:
04/01/2018 - 03/31/2020
Direct Funds:
$50,000 (To build infrastructure and pilot test a local patient registry on which to build a national registry for the H. Jean Khoury Cure CML Consortium.)
  
Title:
Patient-Reported Outcomes for Adherence to Breast Cancer Therapy
Source:
MCW Cancer Center Multiple Principal Investigator Pilot Grant
Role & Effort:
Principal Investigator
PI:
Neuner and Flynn
Dates:
05/01/2018 - 04/30/2020
Direct Funds:
$50,000 (To identify patients who have low adherence to adjuvant breast cancer endocrine therapy through the electronic health record and demonstrate feasibility of a PRO-based symptom monitoring and management intervention. )
  
Title:
Psychometric analysis of PROMIS-29 in light chain amyloidosis
Source:
MCW Clinical and Translational Science Institute start-up
Role & Effort:
Co-investigator
PI:
D'Souza, Anita
Dates:
09/01/2018 - 03/31/2019
Direct Funds:
$12,500 (To evaluate the validity and reliability of the 7 domains included in the PROMIS profile 29 in patients with light chain amyloidosis.)
  
Title:
Qualitative Evaluation of Patient Reported Outcome Measures in Chimeric Antigen Receptor T-Cell Therapy
Source:
Novartis
Role & Effort:
Principal Investigator
PI:
Flynn, Kathryn
Dates:
11/05/2020 - 12/31/2021
Direct Funds:
$263,625 ( To explore patient experiences of chimeric antigen receptor T-cell therapy, evaluate content validity of pre-selected PROMIS patient-reported outcome measures, and identify any gaps in our plan for patient-reported outcome measurement in the context of a long-term clinical registry. )
  
Title:
HJKC3-0006: Real World Outcome of Patients with CML Treated on Second Line or Later Therapy
Source:
Takeda
Role & Effort:
Principal Investigator
PI:
Atallah, Flynn, Thompson, Mauro
Dates:
2023 - 2024
Direct Funds:
$737,154
  

INVITED LECTURES/WORKSHOPS/PRESENTATIONS:
International
Flynn KE, Patient Reported Outcomes Measurement Information System (PROMIS), Presented at the Patient-Focused Cancer Care Outcomes: A Core Set of Validated Measures for Canada executive committee meeting, Toronto General Hospital, Toronto ON, Canada, 05/10/2010
Flynn KE, Using the PROMIS Assessment Center, Presented to Cancer Care Ontario executive leadership, Toronto General Hospital; Toronto, ON, Canada, 12/02/2011
Flynn KE, Introduction to the Patient Reported Outcomes Measurement Information System (PROMIS), Presented to Cancer Care Ontario executive leadership, Toronto General Hospital; Toronto, ON, Canada, 12/02/2011
Flynn KE, Development and Validation of the PROMIS Sexual Function Measure, Presented to Cancer Care Ontario executive leadership, Toronto General Hospital, Toronto, ON, Canada, 12/02/2011
Flynn KE, The use of patient-reported outcome measures in clinical care.” Department of Learning, Informatics, Management, and Ethics, Karolinska Institutet, Solna, Sweden, 01/28/2020
Flynn KE, Development and Validation of the PROMIS Sexual Function Measure.” Health Care Sciences Doctoral Program, Karolinska Institutet, Solna, Sweden, 01/29/2020
 
National
Flynn KE, Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial, Presented at the Health Innovation Program (HIP) Seminar Series, University of Wisconsin; Madison, WI, USA, 07/01/2009
Flynn KE, Incorporating sexual diversity into clinical research, Presented at the Profiles in Sexuality Research series co-sponsored by the Program in the Study of Sexualities at Duke and the Duke University Center for LGBT Life, Duke University, Durham, NC, USA, 01/27/2010
Flynn KE, Personality and healthcare decision-making style, Presented at the First Gavriel Salvendy International Symposium on Frontiers in Industrial Engineering: Cultural Factors in Decision Making and Action, Purdue University, West Lafayette, IN, USA, 04/24/2010
Flynn KE, Assessing Sexual Health in Cancer Survivors, Presented at the Cancer Survivorship and Sexual Health Symposium sponsored by the International Society for Sexual Medicine and the Sexual Medicine Society of North America, Washington DC, USA, 06/18/2011
Flynn KE, Barriers and Solutions to Adopting Central IRB Review for Multicenter Trials, Presented to the Clinical Trials Transformation Initiative's Expert Meeting on Use of Central IRBs for Multicenter Clinical Trials, Bethesda, MD, USA, 04/25/2012
Flynn KE, Development and Validation of the PROMIS Sexual Function Measure, Presented at NCI's Sixth Biennial Cancer Survivorship Research Conference, Arlington, VA, USA, 06/15/2012
Flynn KE, Use of Central IRBs for Multicenter Trials.” Confronting Challenges to Study Start Up, BIO International Convention, Chicago, IL, USA, 04/24/2013
Flynn, KE, Self-reporting Sexual Problems in a Clinical Context, Scientific Network of Female Sexual Health and Cancer’s 4th Conference, Durham, NC, USA, 09/27/2013
Flynn KE, How Do We Make Patient-Reported Health Measures Available as Endpoints in Pragmatic Clinical Trials?”, NIH Collaboratory Grand Rounds, Webinar, 04/10/2015
Flynn KE, Measuring Sexual Functioning in Cancer Patients: PROMIS SexFS, National Cancer Institute Division of Cancer Control and Prevention, Rockville, MD, USA, 07/15/2015
Flynn KE, Introduction to the PROMIS® SexFS, PROMIS Health Organization, Webinar, 01/27/2016
Flynn KE, Measuring Sexual Functioning in Clinical Research: the PROMIS SexFS, Food and Drug Administration Center for Drug Evaluation and Research, White Oak, MD, USA, 05/09/2016
Flynn KE, Female Sexual Health and Cancer, International Society for the Study of Women’s Sexual Health, Atlanta, GA, USA, 02/24/2017
Flynn KE, Network Registry Harmonization Progress Report, Scientific Network on Female Sexual Health and Cancer Conference, Sacramento, CA, USA, 04/07/2017
Flynn KE, Engaging Psychometricians in Benign Urologic Conditions Research, Individualizing Urinary Incontinence Treatment: Evolving Research Questions to Research Plans, National Institute of Diabetes and Digestive and Kidney Diseases, Rockville, MD, USA, 02/01/2018
Flynn KE, Cellular Therapy and Real-World Experience: Patient-Reported Outcomes, Cellular Therapy Registry Forum, Bethesda, MD, USA, 10/03/2019
Flynn KE, Measurement of Sexual Function and Satisfaction for Research, Scientific Network on Female Sexual Health and Cancer Virtual Conference, Virtual, 04/09/2021
Flynn KE, Patient-Reported Outcomes for Research, American Society for Transplantation and Cellular Therapy Value and Health Economics Special Interest Group, Webinar, 10/19/2021
Flynn KE, Cognitive interviews for improving patient-reported outcome measures, Patient Centered Outcomes Research webinar, The Ohio State University, 04/14/2023
 
Regional
Flynn KE, My experience on the FDA’s Advisory Committee for the review of flibanserin (‘female Viagra’), Interdisciplinary Sexuality Seminar, University of Wisconsin, Madison, WI, USA, 03/31/2017
 
Local
Flynn KE, Development of a PROMIS item bank for use in cancer and other chronic conditions, Center for Patient Care and Outcomes Research seminar, Medical College of Wisconsin, Milwaukee, WI, USA, 06/08/2012
Flynn KE, Using PROMIS to assess self-reported health, Clinical and Translational Science Institute research seminar, Medical College of Wisconsin, Milwaukee, WI, USA, 02/20/2014
Flynn KE, Development of the PROMIS Sexual Function and Satisfaction Measure, Interdisciplinary Sexuality Seminar of the University of Wisconsin Madison and the Medical College of Wisconsin Center for Aids Intervention Research (CAIR), Milwaukee, WI, USA, 03/28/2014
Flynn KE, Use of PROMIS measures in the LAST study of patients with CML, Medical College of Wisconsin Cancer Center Scientific Retreat, Milwaukee, WI, USA, 03/20/2015
Flynn KE, Use of PROMIS in research, Marquette University’s Building Bridges to Research Based Nursing Practice Conference, Milwaukee, WI, USA, 05/08/2015
Flynn KE, The FDA’s 2015 advisory committee for review of flibanserin, Center for Patient Care and Outcomes Research seminar, Medical College of Wisconsin, Milwaukee, WI, USA, 09/11/2015
Flynn KE, Overview of PROMIS measures and their use in the LAST study of patients with CML, Hematology and Oncology Division Research Meeting, Medical College of Wisconsin, Milwaukee, WI, USA, 08/17/2017
Flynn KE, Overview of NIDDK’s Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN), Geriatrics Division Seminar, Medical College of Wisconsin, Milwaukee, WI, USA, 05/04/2018
Flynn KE, PROMIS and other patient-reported outcomes in cardiology, Cardiovascular Center Seminar Series, Medical College of Wisconsin, Milwaukee, WI, USA, 07/18/2018
Flynn KE, The role of patient-reported outcomes in patient-centered cardiology care, Cardiology Grand Rounds, Medical College of Wisconsin, Milwaukee, WI, USA, 10/04/2018
Flynn KE, Patient-reported outcomes in oncology care, Cancer Prevention & Outcomes (CPO) Research Program, Medical College of Wisconsin, Milwaukee, WI, USA, 11/16/2018
Flynn KE, The Life After Stopping Tyrosine Kinase Inhibitors (LAST) Study, Daniel McCarty Lecture, Department of Medicine Research Retreat, Medical College of Wisconsin, Milwaukee, WI, USA, 03/06/2020
Flynn KE, Curing CML: Where do we go from here?, Cancer Center’s Cancer Prevention & Outcomes Seminar, Medical College of Wisconsin, Milwaukee, WI, USA, 09/24/2021
 

PEER REVIEWED WORKSHOPS/PRESENTATIONS:
International
Flynn KE, Smith MA, Psychological traits and preference for control over health care decisions, Oral presentation at the International Conference of the European Association for Communication in Healthcare, Bruges, Belgium, 09/14/2004 - 09/17/2004
Flynn KE, Smith MA, Vanness D, Patient preferences for participation in decision making, Oral presentation at the International Shared Decision Making Conference, Ottawa, Canada, 06/14/2005 - 06/16/2005
Flynn KE, Weinfurt KP, Seils DM, Burnett CB, Schulman KA, Meropol NJ, Decisional conflict among patients who accept or decline participation in phase I oncology studies, Poster presentation at the Society for General Internal Medicine Annual Meeting, Toronto, ON, Canada, 04/25/2007
Flynn KE, Dombeck C, DeWitt EM, Diener LW, Schulman KA, Weinfurt KP, Flynn KE, Dombeck C, DeWitt EM, Diener LW, Schulman KA, Weinfurt KP, Poster presentation at the Society for General Internal Medicine Annual Meeting, Toronto, ON, Canada, 04/25/2007
Jeffery DD, Reeve BB, Tzeng J, Weinfurt KP, Flynn KE, Keefe FJ, Porter LS, Hahn EA, Cella D, the PROMIS Sexual Function Committee, The sexual function domain of the NIH PROMIS: preliminary report, Poster presentation at the World Congress of Psycho-Oncology, London, England, 09/15/2007
Flynn KE, Tzeng J, Jeffery DD, Reeve BB, Weinfurt KP, the PROMIS Sexual Function Committee, Conceptualizations of sexual functioning and intimacy among cancer sufferers and survivors, Poster presentation at the World Congress of Psycho-Oncology, London, England, 09/15/2007
Flynn KE, Weinfurt KP, Seils DM, Burnett CB, Schulman KA, Meropol NJ, Decisional conflict among patients who accept or decline participation in phase I oncology studies, Poster presentation at the World Congress of Psycho-Oncology, London, England, 09/15/2007
Flynn KE, Jeffery DD, Reeve BB, Lin L, Wilder Smith A, Abernethy AP, Reese JB, Weinfurt KP, Progress on the PROMIS® Sexual Function Measure, Poster presentation at the International Society for Quality of Life Research Annual Conference, London, England, 10/29/2010
Flynn KE, Weinfurt KP (presenter), Lin L, Jeffery DD, Reese JB, & the PROMIS Sexual Function Domain Group, Development and validation of the PROMIS Vulvar Discomfort with Sexual Activity scales, Oral presentation at the World Meeting on Sexual Medicine (Awarded Best Abstract Prize, $2500), Sao Paolo, Brazil, 10/10/2014
Flynn KE, Lindau ST, Lin L, Carter J, Jeffery DD, Reese JB, Abramsohn EM, Weinfurt KP, Development and validation of a single item screener for self-reported sexual problems, Poster presentation at the Annual International Society for Quality of Life Research Conference, Berlin, Germany, 10/16/2014
D’Souza A, Pasquini M, Hari P, Jacobson K, Flynn K, Patient-reported outcomes in light chain amyloidosis: choosing the optimal tool, Poster presentation at the International Symposium on Amyloidosis, Uppsala, Sweden, 07/2016
Flynn KE, Lin L, Weinfurt KP, Recent sexual function and satisfaction by sexual orientation in U.S. adults, Oral presentation at the International Society for Quality of Life Research Conference, Copenhagen, Denmark, 10/21/2016
Duthie EA, Cooper A, Davis JB, Sandlow J, Schoyer KD, Strawn E, & Flynn KE, Shared decision making with multiple stakeholders: in vitro fertilization and embryo transfer, Poster presentation at the North American Meeting of the Society for Medical Decision Making, Vancouver, BC, Canada, 10/26/2016
Mason SF, Dasgupta M, Simpson PM, Flynn KE, Singh A, Comparison of CAT and short forms for PROMIS pediatric pain and physical functioning domains in children with sickle cell disease, Oral presentation at the International Society for Quality of Life Research Conference, Prague, Czech Republic, 10/20/2022
Cusatis R, Matilla D, Berman L, Ndifon E, Shaw BE, Flynn KE, Making strides with room to grow: Early evidence for incorporating PROs into an established clinical outcomes registry, Oral presentation at the International Society for Quality of Life Research Conference, Prague, Czech Republic, 10/22/2022
Flynn KE, Tiegs J, Sparapani R, Stolley M, Kamaraju S, Neuner J, Distress among older women prescribed adjuvant endocrine therapy to prevent breast cancer recurrence, Oral presentation at the International Society for Quality of Life Research Conference, Calgary, Alberta, Canada, 10/20/2023
 
National
Flynn KE, The role of uncertainty in the breastfeeding decision for black and white women, Poster presentation at the Academy for Health Services Research and Health Policy Annual Research Meeting, Nashville, TN, 06/27/2003 - 06/29/2003
Flynn KE, Smith MA, Psychological traits and preference for control over health care decisions, Oral presentation at the National Research Service Award (NRSA) Trainee Conference, San Diego, CA, 06/05/2004
Flynn KE, Smith MA, Psychological traits and preference for control over health care decisions, Poster presentation at the Academy for Health Services Research and Health Policy Annual Research Meeting, San Diego, CA, 06/06/2004 - 06/08/2004
Flynn KE, Smith MA, Vanness D, Patient preferences for participation in decision making, Panel presentation at the Academy for Health Services Research and Health Policy Annual Research Meeting, Boston, MA, 06/26/2005 - 06/28/2005
Flynn KE, Smith MA, Life course factors predicting preferences for healthcare decision making, Oral presentation at the International Conference on Communication in Healthcare, Chicago, IL, 10/05/2005 - 10/05/2008
Flynn KE, Smith MA, Freese J, How Older Adults Use the Internet to Look for Health Information, Oral presentation at the AcademyHealth Annual Research Meeting, Seattle, WA, 06/27/2006
Flynn KE, Weinfurt KP, Incorporating item banks into clinical trials: Preliminary data on trialists’ concerns, Oral presentation at the Inaugural PROMIS Conference, Rockville, MD, 09/11/2006
Flynn KE, DeWitt EM, Dombeck C, Diener LW, Schulman KA, Weinfurt KP, Working With Item Banks in Clinical Trials: Investigator Perceptions, Poster presentation at the National Cancer Institute’s Patient Reported Outcomes Assessment in Clinical Trials (PROACT) Conference, Bethesda, MA, 09/20/2006
Flynn KE, Weinfurt KP, Seils DM, Burnett CB, Schulman KA, Meropol NJ, Decisional conflict among patients who accept or decline participation in phase I oncology studies, Oral presentation at the AcademyHealth Annual Research Meeting, Orlando, FL, 06/03/2007
Flynn KE, Dombeck C, DeWitt EM, Diener LW, Schulman KA, Weinfurt KP, Incorporating item banks into clinical trials: investigator perceptions, Poster presentation at the AcademyHealth Annual Research Meeting, Orlando, FL, 06/03/2007
Flynn KE, Shelby R, Krystal A, Reeve BB, Mitchell S, Buysse D, Keefe F, Weinfurt KP, the PROMIS Sleep-Wake Functioning Committee, Sleep/wake functioning during and following cancer, Poster presentation at the PROMIS Conference, Bethesda, MD, 03/03/2008 - 03/05/2008
Flynn KE, Tzeng J, Jeffery DD, Reeve BB, Weinfurt KP, the PROMIS Sexual Function Committee, Conceptualizations of sexual functioning and intimacy among cancer sufferers and survivors, Poster presentation at the PROMIS Conference, Bethesda, MD, 03/03/2008 - 03/05/2008
Fortune-Greeley A, Williams MS, Flynn KE, Weinfurt KP, the PROMIS Sexual Function Committee, Developing a universal sexual function measure: Lessons learned from cognitive interviews, Poster presentation at the Annual Meeting and Scientific Sessions of the Society of Behavioral Medicine, San Diego, CA, 03/28/2008
Flynn KE, Lin L, Ellis SJ, Fine L, Pina I, Roll SK, Russell S. Schulman KA, Spertus J, Whellan D, Weinfurt KP, Relationships among the Kansas City Cardiomyopathy Questionnaire and clinical measures in patients with heart failure, Oral presentation at the Scientific Session of the American College of Cardiology, Chicago, IL, 04/01/2008
Flynn KE, Shelby R, Krystal A, Reeve BB, Mitchell S, Buysse D, Keefe F, Weinfurt KP, the PROMIS Sleep-Wake Functioning Committee, Sleep/wake functioning during and following cancer, Poster presentation at SLEEP the Annual Meeting of the Associated Professional Sleep Societies, Baltimore, MD, 06/11/2008
Flynn KE, Piña IL, Lin L, Blumenthal JA, Cooper LS, Ellis SJ, Fine LJ, Keteyian SJ, Kitzman DW, Kraus WE, Miller NH, O’Connor CM, Spertus JA, Whellan DJ, Schulman KA, Weinfurt KP, Effect of exercise training on health-related quality of life in patients with chronic heart failure: an HF-ACTION substudy, Late Breaking Clinical Trials oral presentation at the American Heart Association Scientific Sessions, New Orleans, LA, 11/12/2008
Flynn KE,Weinfurt KP, the PROMIS Sexual Function Committee, Patient-provider communication about sex during and following treatment for cancer: Insights from the PROMIS Sexual Function measure development, Poster presentation at the AcademyHealth Annual Research Meeting, Chicago, IL, 06/29/2009
Flynn KE, Patient-Reported Outcomes Measurement Information System (PROMIS) in cancer, Workshop presentation at the American Psychosocial Oncology Society Conference, Anaheim, CA, 02/17/2011
Check D, Kramer J, Weinfurt K, Flynn KE, The Use of Central IRBs for Multicenter Clinical Trials, Oral presentation at the Annual Meeting of the Society for Clinical Trials, Miami, FL, 05/22/2012
Moore A, Flynn KE, Jeffery J, Hahn EA, Reeve B, Keefe F, Lai, J-S, Weinfurt K., Patients' understanding of common terms used in self-reported measures of sexual function, Oral presentation at the World Meeting on Sexual Medicine, Chicago, IL, 08/27/2012
Flynn KE, Reese JB, Bruner D, Dombeck C, Keefe F, Magasi S, Reeve B, Shelby R, Weinfurt K., Patients' understanding of interest, desire, and arousal, Moderated poster presentation at the World Meeting on Sexual Medicine, Chicago, IL, 08/28/2012
Flynn KE, Hahn C, Check D, Kramer J, Muhlbaier L, Perlmutter J, Weinfurt KP, Use of central institutional review boards for multicenter clinical trials, Moderated poster presentation at the Advancing Ethical Research Conference (PRIM&R), San Diego, CA, 12/05/2012
Flynn KE, Lin L, Keefe FJ, Reese JB, Weinfurt KP, The Vulvar Discomfort domain of the PROMIS Sexual Function and Satisfaction measure, Poster presentation at the Annual International Society for Quality of Life Research Conference, Miami, FL, 10/11/2013
Flynn KE, Cyranowski JM, Dombeck CB, Jeffery DJ, Magasi S, Moore A, Reese JB, Reeve BB, Shelby RA, Weinfurt KP, & the PROMIS Sexual Function Domain Group, Conceptual model for the PROMIS Sexual Function and Satisfaction measure, Oral presentation at Annual International Society for Quality of Life Research Conference, Miami, FL, 10/12/2013
Duthie EA, Cooper A, Strawn E, & Flynn KE, Infertility-related decision making and decisional conflict, Oral presentation at the Annual Meeting of the Society for Medical Decision Making, Miami, FL, 10/22/2014
Duthie E, Cooper A, Lyerly A, Strawn E, & Flynn K, Family-building priorities for couples seeking care for infertility, Oral presentation at the American Public Health Association Annual Meeting, New Orleans, LA, 11/19/2014
Flynn KE, Duthie EA, Health-related quality of life in couples seeking treatment for infertility, Poster presentation at the PROMIS Health Organization (PHO) conference, Philadelphia, PA, 05/15/2015
Miller SJ, Schoyer KD, Wozniak E, Davis J, Sandlow J, Strawn E, Flynn KE, Patient perspectives on IVF success and likelihood of multiple gestations, Poster presentation at the American Society for Reproductive Medicine, Baltimore, MD, 10/21/2015
Flynn KE, Schiffer CA, Thompson J, Atallah E, Patient decision making about TKI treatment discontinuation, Poster presentation at the Annual John Goldman Conference on Chronic Myeloid Leukemia: Biology and Therapy, Houston, TX, 10/16/2016
Duthie EA, Cooper A, Davis JB, Sandlow J, Schoyer KD, Strawn E, & Flynn KE, Infertility and family-building priorities, Oral presentation at the American Society for Reproductive Medicine 2016 Scientific Congress, Salt Lake City, UT, 10/17/2016
26. Flynn K, Cox ED, Kliems H, Saoji N, and Svenson J, Validity and clinical utility of the PROMIS family relationships measure in children with chronic conditions, Oral presentation at the PROMIS Health Organization Conference, Philadelphia, PA, 10/17/2017
Adenuga OS, Duthie EA, Cooper A, Davis JB, Schoyer KD, Sandlow J, Strawn E, & Flynn KE, Patient attitudes towards the use of autologous cryopreserved embryos for fertility treatment, Poster presentation at the American Society for Reproductive Medicine 2017 Scientific Congress, San Antonio, TX, 10/31/2017
D’Souza A, Millard HR, Knight J, Brazauskas R, Vogel J, Mattila D, Flynn K, Lee SJ, Horowitz MM, Rizzo JD, Shaw BE, Patient-reported sleep quality at baseline correlates with 1-year survival after allogeneic hematopoietic cell transplantation in adults, Poster presentation at the American Society of Hematology Meeting, Atlanta, GA, 12/10/2017
Flynn KE, Patient-reported outcomes (PRO) in CAR-T cell therapy, Oral presentation at the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) Meeting on Chimeric Antigen Receptor (CAR) T-Cell Therapy and Patient Reported Outcomes, Centers for Medicare & Medicaid Services, Baltimore, MD, 08/22/2018
Flynn KE, Mansfield SA, Smith AR, Gillespie BW, Bradley CS, Clemens JQ, Helmuth ME, Talaty P, Lai HH, Kirkali Z, Weinfurt KP and the LURN Study Group, MP29-08 Accuracy of 7- and 30-day recall for self-reported lower urinary tract symptoms (Best Poster Award), Moderated poster presentation at the American Urological Association Annual Meeting, Chicago, IL, 05/04/2019
Anguzu R, Cusatis R, Fergestrom N, Schoyer KD, Sandlow J, Flynn KE, Decision-making and decisional conflict among couples seeking treatment for infertility, Poster presentation at the American Public Health Association Annual Meeting, Philadelphia, PA, 11/03/2019
Flynn KE, Weinfurt KP, Lin L, Radich JP, Schiffer CA, Mauro MJ, Pinilla-Ibarz, J, Moore JO, Larson RA, Oehler V, Deininger MW, Thompson JE, Shah NP, Wadleigh M, Ritchie EK, Silver RT, Cortes JE, Kota V, Atallah EL, Patient-reported outcome results from the U.S. Life after Stopping TKIs (LAST) study in patients with chronic myeloid leukemia, Oral presentation at the American Society of Hematology Meeting, Orlando, FL, 12/09/2019
Flynn KE, Mansfield SA, Smith AR, Gillespie BW, Bradley CS, Cella D, Helmuth ME, Lai H, Kirkali Z, Talaty P, and Weinfurt KP, MP27-02 Personal characteristics associated with 30-day recall of self-reported lower urinary tract symptoms (Best Poster Award), Moderated poster presentation at the American Urological Association Virtual Science, May 16, 2020, 05/16/2020
Shaw BE, Flynn KE, Cusatis R, D'Souza A, Hamilton BK, Horowitz MM, Mattila D, Phelan R, Lee S, Brazauskas R., Incorporating patient-reported outcome data into a hematopoietic cell transplant survival calculator, Poster presentation at the American Society of Clinical Oncology Meeting, Chicago, IL, 06/04/2022
Cusatis R, Tecca HR, D’Souza A, Shaw BE, Flynn KE, Decisional regret in the first year after hematopoietic cell transplantation, Poster presentation at the International Society for Quality of Life Research Conference (New Investigator Poster Award), San Diego, CA, 10/2022
Balza J, Flynn KE, Leveraging the perspectives and experiences of landlords and property managers for lead poisoning prevention, Poster presentation at the American Public Health Association Annual Meeting, Atlanta, GA, 11/13/2023
 
Regional
Flynn KE, Shelby RA, Porter LS, Jeffery DD, Keefe FJ, the PROMIS Sexual Function Subcommittee, Weinfurt KP, Patient-provider communication about sex during and following treatment for cancer: Insights from the PROMIS Sexual Function focus groups, Oral presentation at the American Academy on Communication in Healthcare Research and Teaching Forum, Madison, WI, 10/19/2008
 
Local
Cusatis R, Flynn KE, Lewandowski L, Survey Design and Execution: Asking the Right Questions to Get the Right Answers, Oral presentation at the 2018 Innovations in Healthcare Education Research Conference, Medical College of Wisconsin, Milwaukee, WI, 04/26/2018
 

EXTRAMURAL TEACHING:
Medical Student Education
09/1998 - 12/1998 University of Minnesota Department of Sociology, Teaching Assistant and Laboratory Instructor, Descriptive Statistics
01/1999 - 03/1999 University of Minnesota Department of Sociology, Teaching Assistant and Laboratory Instructor, Inferential Statistics
03/1999 - 06/1999 University of Minnesota Department of Sociology, Teaching Assistant and Laboratory Instructor, Research Methods
 
Pharmacy Student Education
02/2018 - 02/2022 Medical College of Wisconsin School of Pharmacy, Guest Lecturer, “Patient-Reported Outcomes”, Evidence Based Practice
 
Graduate Student Education
09/2011 - 02/2012 Duke University Physician Assistant Training Program, Course Lecturer and Small Group Instructor, Evidence-based Medicine II
Duke University School of Nursing, Course Director and Instructor, Research Methods 08/2011-12/2011, 01/2012-05/2012, 05/2012-08/2012
Medical College of Wisconsin Institute for Health & Equity, Founding Course Director and Instructor, 3-credit semester-long course, Survey Research Methods 08/2014-12/2014, 01/2016-05/2016, 08/2018-12/2018, 08/2020-12/2020, 08/2022-12/2022
Duke University Physician Assistant Training Program, Small Group Instructor for weekly discussion groups, Evidence-based Medicine I 03/2008-05/2008, 10/2010-12/2010, 10/2011-12/2011
 

MCW STUDENTS, FACULTY, RESIDENTS AND CLINICAL/RESEARCH FELLOWS MENTORED:
Medical Students
01/2019 - 12/2019 Caroline Davitt, Research mentor, research project in Obstetrics & Gynecology, Medical College of Wisconsin
07/2019 - 12/2019 Megan Reinhard, Research mentor, research project in Obstetrics & Gynecology, Medical College of Wisconsin
Oluwatosin Adenuga, 01/2015-06/2018 Pathway advisor and faculty mentor, Global Health Pathway 06/2016-08/2016 Research project advisor, Medical Student Summer Research Program, Medical College of Wisconsin
Marie Luebke, 05/2022-08/2022 Research project advisor, Medical Student Summer Research Program 09/2021-12/2022 Pathway advisor and faculty mentor, Research Intensive Pathway, Medical College of Wisconsin
Yoon Jin (Amy) Lee, 05/2022-08/2022 Research project advisor, Medical Student Summer Research Program 09/2021-12/2022 Pathway advisor and faculty mentor, Research Intensive Pathway, Medical College of Wisconsin
 
Graduate Students
PhD Committees
07/2013 - 01/2014 Zeno Franco, PhD, Medical College of Wisconsin, MS program in Clinical & Translational Science
10/2014 - 06/2017 Laila Azam, Medical College of Wisconsin, PhD program in Public and Community Health
09/2020 - 05/2024 Joanna Balza, RN, Medical College of Wisconsin, Primary mentor, PhD program in Public and Community Health
 
Postdoctoral Students
09/2012 - 04/2015 Elizabeth Duthie, PhD, Primary Mentor, Medical College of Wisconsin, NIH HRSA T32 Fellowship in Primary Care Research
04/2016 - 05/2019 Ben Holmes, DC, Research mentor, Medical College of Wisconsin, PhD program in Public and Community Health
09/2017 - 09/2019 Ronald Anguzu, MBChB, Research mentor, Medical College of Wisconsin, PhD program in Public and Community Health
10/2017 - 09/2019 Rachel Cusatis, PhD, Primary Mentor, Medical College of Wisconsin, NIH HRSA T32 Fellowship in Primary Care Research
08/2019 - Present Joanna Balza, RN, Research mentor, PhD program in Public and Community Health, Medical College of Wisconsin
 
Residents
09/2014 - 06/2016 Sarah Dobrozsi, MD, Member of Scholarly Oversight Committee for Pediatric Hematology/Oncology/BMT Fellowship, Medical College of Wisconsin
03/2015 - 12/2015 Stephanie Miller, MD, Obstetrics & Gynecology resident, Research mentor, Medical College of Wisconsin
09/2015 - 06/2017 Craig Erker, MD, Member of Scholarly Oversight Committee for Pediatric Hematology/Oncology/BMT Fellowship, Medical College of Wisconsin
08/2016 - 06/2019 Nicole Rau, MD, Neonatology fellow, Research mentor, Medical College of Wisconsin
10/2017 - 06/2019 Arun Singavi, MD, MS, Hematology/Oncology fellow, Research mentor, Medical College of Wisconsin
06/2018 - 12/2019 Gemlyn George, MD, Hematology/Oncology fellow, Research mentor, Medical College of Wisconsin
01/2019 - 12/2019 Sarah Hirsch, MD, Obstetrics & Gynecology resident, Research mentor, Medical College of Wisconsin
 
Faculty
10/2013 - 12/2015 Trafford Crump, PhD, Department of Pediatrics, Member of mentoring team, Medical College of Wisconsin
02/2014 - 02/2024 Anita D’Souza, MD, MS, Department of Medicine, Primary mentor, Medical College of Wisconsin
09/2014 - 09/2019 Mary Rhodes, MD, Department of Medicine, Member of mentoring team, Medical College of Wisconsin
10/2015 - 06/2020 Onur Asan, PhD, Department of Medicine, Member of mentoring team, Medical College of Wisconsin
08/2016 - 06/2020 Abbey Kruper, PsyD, Department of Obstetrics & Gynecology, Member of mentoring team, Medical College of Wisconsin
09/2017 - 06/2022 Aaron Winn, PhD, Department of Clinical Sciences, Member of mentoring team, Medical College of Wisconsin
08/2019 - 06/2021 Kyle Van Arendonk, MD, Department of Surgery, Research mentor, Medical College of Wisconsin
10/2019 - Present Rachel Cusatis, PhD, Department of Medicine, Primary Mentor, Medical College of Wisconsin
08/2020 - 08/2021 Ariel Nelson, MD, Department of Medicine, Research mentor, Medical College of Wisconsin
09/2021 - Present Patrick Murphy, MD, Department of Surgery, Research mentor, Medical College of Wisconsin
09/2021 - 09/2022 Chandler Cortina, MD, Department of Surgery, Research mentor, Medical College of Wisconsin
02/2022 - Present Angela Steineck, MD, Department of Pediatrics, Research mentor, Medical College of Wisconsin
01/2023 - Present Alina Burek, MD, Department of Pediatrics, Primary mentor, Medical College of Wisconsin
 

EXTRAMURAL STUDENTS, FACULTY, RESIDENTS, AND CLINICAL/RESEARCH FELLOWS MENTORED:
Postdoctoral Students
08/2008 - 12/2008 Tracy Gosselin, PhD, Mentor for qualitative research practicum in the PhD program in Nursing, Duke University
09/2009 - 09/2012 Robb Kociol, MD, Cardiovascular disease fellow, Research mentor, Duke University
 


BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. Flynn KE, Smith MA, Davis MK. From physician to consumer: the effectiveness of strategies to manage health care utilization. Med Care Res Rev. 2002 Dec;59(4):455-81. PMCID: PMC1635490
2. Flynn KE, Smith MA, Vanness D. A typology of preferences for participation in healthcare decision making. Soc Sci Med. 2006 Sep;63(5):1158-69. PMCID: PMC1637042
3. Flynn KE, Smith MA, Freese J. When do older adults turn to the internet for health information? Findings from the Wisconsin Longitudinal Study. J Gen Intern Med. 2006 Dec;21(12):1295-301. PMCID: PMC1924748
4. Flynn KE, Smith MA. Personality and health care decision-making style. J Gerontol B Psychol Sci Soc Sci. 2007 Sep;62(5):P261-7. PMCID: PMC2211430
5. Garcia SF, Cella D, Clauser SB, Flynn KE, Lad T, Lai JS, Reeve BB, Smith AW, Stone AA, Weinfurt K. Standardizing patient-reported outcomes assessment in cancer clinical trials: a patient-reported outcomes measurement information system initiative. J Clin Oncol. 2007 Nov 10;25(32):5106-12.
6. Flynn KE, Weinfurt KP, Seils DM, Lin L, Burnett CB, Schulman KA, Meropol NJ. Decisional conflict among patients who accept or decline participation in phase I oncology studies. J Empir Res Hum Res Ethics. 2008 Sep;3(3):69-77. PMCID: PMC2613310
7. Flynn KE, Dombeck CB, DeWitt EM, Schulman KA, Weinfurt KP. Using item banks to construct measures of patient reported outcomes in clinical trials: investigator perceptions. Clin Trials. 2008;5(6):575-86. PMCID: PMC2662709
8. Pandhi N, Schumacher J, Flynn KE, Smith M. Patients' perceptions of safety if interpersonal continuity of care were to be disrupted. Health Expect. 2008 Dec;11(4):400-8. PMCID: PMC2689380
9. Jeffery DD, Tzeng JP, Keefe FJ, Porter LS, Hahn EA, Flynn KE, Reeve BB, Weinfurt KP. Initial report of the cancer Patient-Reported Outcomes Measurement Information System (PROMIS) sexual function committee: review of sexual function measures and domains used in oncology. Cancer. 2009 Mar 15;115(6):1142-53. PMCID: PMC2742328
10. Flynn KE, Piña IL, Whellan DJ, Lin L, Blumenthal JA, Ellis SJ, Fine LJ, Howlett JG, Keteyian SJ, Kitzman DW, Kraus WE, Miller NH, Schulman KA, Spertus JA, O'Connor CM, Weinfurt KP, HF-ACTION Investigators. Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA. 2009 Apr 08;301(14):1451-9. PMCID: PMC2690699
11. Fortune-Greeley AK, Flynn KE, Jeffery DD, Williams MS, Keefe FJ, Reeve BB, Willis GB, Weinfurt KP, PROMIS Sexual Function Domain Committee. Using cognitive interviews to evaluate items for measuring sexual functioning across cancer populations: improvements and remaining challenges. Qual Life Res. 2009 Oct;18(8):1085-93. PMCID: PMC2759179
12. Flynn KE, Shelby RA, Mitchell SA, Fawzy MR, Hardy NC, Husain AM, Keefe FJ, Krystal AD, Porter LS, Reeve BB, Weinfurt KP. Sleep-wake functioning along the cancer continuum: focus group results from the Patient-Reported Outcomes Measurement Information System (PROMIS(®)). Psychooncology. 2010 Oct;19(10):1086-93. PMCID: PMC2888823
13. Flynn KE, Jeffery DD, Keefe FJ, Porter LS, Shelby RA, Fawzy MR, Gosselin TK, Reeve BB, Weinfurt KP. Sexual functioning along the cancer continuum: focus group results from the Patient-Reported Outcomes Measurement Information System (PROMIS®). Psychooncology. 2011 Apr;20(4):378-86. PMCID: PMC3013236
14. Flynn KE, Lin L, Moe GW, Howlett JG, Fine LJ, Spertus JA, McConnell TR, Piña IL, Weinfurt KP. Relationships between changes in patient-reported health status and functional capacity in outpatients with heart failure. Am Heart J. 2012 Jan;163(1):88-94.e3. PMCID: PMC3258582
15. Flynn KE, Reese JB, Jeffery DD, Abernethy AP, Lin L, Shelby RA, Porter LS, Dombeck CB, Weinfurt KP. Patient experiences with communication about sex during and after treatment for cancer. Psychooncology. 2012 Jun;21(6):594-601. PMCID: PMC3149787
16. Kociol RD, Peterson ED, Hammill BG, Flynn KE, Heidenreich PA, Piña IL, Lytle BL, Albert NM, Curtis LH, Fonarow GC, Hernandez AF. National survey of hospital strategies to reduce heart failure readmissions: findings from the Get With the Guidelines-Heart Failure registry. Circ Heart Fail. 2012 Nov;5(6):680-7.
17. Flynn KE, Lin L, Ellis SJ, Russell SD, Spertus JA, Whellan DJ, Piña IL, Fine LJ, Schulman KA, Weinfurt KP, HF-ACTION Investigators. Outcomes, health policy, and managed care: relationships between patient-reported outcome measures and clinical measures in outpatients with heart failure. Am Heart J. 2009 Oct;158(4 Suppl):S64-71. PMCID: PMC2805910
18. Flynn KE, Hahn CL, Kramer JM, Check DK, Dombeck CB, Bang S, Perlmutter J, Khin-Maung-Gyi FA, Weinfurt KP. Using central IRBs for multicenter clinical trials in the United States. PLoS One. 2013;8(1):e54999. PMCID: PMC3559741
19. Flynn KE, Reeve BB, Lin L, Cyranowski JM, Bruner DW, Weinfurt KP. Construct validity of the PROMIS® sexual function and satisfaction measures in patients with cancer. Health Qual Life Outcomes. 2013 Mar 11;11:40. PMCID: PMC3618202
20. Flynn KE, Kramer JM, Dombeck CB, Weinfurt KP. Participants' perspectives on safety monitoring in clinical trials. Clin Trials. 2013 Aug;10(4):552-9.
21. Flynn KE, Lin L, Cyranowski JM, Reeve BB, Reese JB, Jeffery DD, Smith AW, Porter LS, Dombeck CB, Bruner DW, Keefe FJ, Weinfurt KP. Development of the NIH PROMIS ® Sexual Function and Satisfaction measures in patients with cancer. J Sex Med. 2013 Feb;10 Suppl 1(0 1):43-52. PMCID: PMC3729213
22. Williams MS, Snyder DC, Sloane R, Levens J, Flynn KE, Dombeck CB, Demark-Wahnefried W, Weinfurt KP. A comparison of cancer survivors from the PROMIS study selecting telephone versus online questionnaires. Psychooncology. 2013 Nov;22(11):2632-5. PMCID: PMC3808510
23. Piña IL, Lin L, Weinfurt KP, Isitt JJ, Whellan DJ, Schulman KA, Flynn KE, HF-ACTION Investigators. Hemoglobin, exercise training, and health status in patients with chronic heart failure (from the HF-ACTION randomized controlled trial). Am J Cardiol. 2013 Oct 01;112(7):971-6.
24. Weinfurt KP, Lin L, Dombeck CB, Broderick JE, Snyder DC, Williams MS, Fawzy MR, Flynn KE. Accuracy of 30-day recall for components of sexual function and the moderating effects of gender and mood. J Sex Med. 2014 Mar;11(3):678-96. PMCID: PMC3818437
25. Check DK, Weinfurt KP, Dombeck CB, Kramer JM, Flynn KE. Use of central institutional review boards for multicenter clinical trials in the United States: a review of the literature. Clin Trials. 2013 Aug;10(4):560-7.
26. Duthie EA, Drew EM, Flynn KE. Patient-provider communication about gestational weight gain among nulliparous women: a qualitative study of the views of obstetricians and first-time pregnant women. BMC Pregnancy Childbirth. 2013 Dec 11;13:231. PMCID: PMC4029598
27. Alexander AM, Flynn KE, Hahn EA, Jeffery DD, Keefe FJ, Reeve BB, Schultz W, Reese JB, Shelby RA, Weinfurt KP. Improving patients' understanding of terms and phrases commonly used in self-reported measures of sexual function. J Sex Med. 2014 Aug;11(8):1991-8. PMCID: PMC4248305
28. Flynn KE, Lindau ST, Lin L, Reese JB, Jeffery DD, Carter J, Baron SR, Abramsohn E, Weinfurt KP. Development and Validation of a Single-Item Screener for Self-Reporting Sexual Problems in U.S. Adults. J Gen Intern Med. 2015 Oct;30(10):1468-75. PMCID: PMC4579234
29. Jeffery DD, Barbera L, Andersen BL, Siston AK, Jhingran A, Baron SR, Reese JB, Coady DJ, Carter J, Flynn KE. Self-Reported Sexual Function Measures Administered to Female Cancer Patients: A Systematic Review, 2008-2014. J Psychosoc Oncol. 2015;33(4):433-66. PMCID: PMC4992993
30. Gellad WF, Flynn KE, Alexander GC. Evaluation of Flibanserin: Science and Advocacy at the FDA. JAMA. 2015 Sep 01;314(9):869-70.
31. Flynn KE, Dew MA, Lin L, Fawzy M, Graham FL, Hahn EA, Hays RD, Kormos RL, Liu H, McNulty M, Weinfurt KP. Reliability and construct validity of PROMIS® measures for patients with heart failure who undergo heart transplant. Qual Life Res. 2015 Nov;24(11):2591-9. PMCID: PMC4593724
32. Weinfurt KP, Lin L, Bruner DW, Cyranowski JM, Dombeck CB, Hahn EA, Jeffery DD, Luecht RM, Magasi S, Porter LS, Reese JB, Reeve BB, Shelby RA, Smith AW, Willse JT, Flynn KE. Development and Initial Validation of the PROMIS(®) Sexual Function and Satisfaction Measures Version 2.0. J Sex Med. 2015 Sep;12(9):1961-74.
33. Shaw BE, Lee SJ, Horowitz MM, Wood WA, Rizzo JD, Flynn KE. Can we agree on patient-reported outcome measures for assessing hematopoietic cell transplantation patients? A study from the CIBMTR and BMT CTN. Bone Marrow Transplant. 2016 Sep;51(9):1173-9.
34. Asan O, Holden RJ, Flynn KE, Yang Y, Azam L, Scanlon MC. Provider Use of a Novel EHR display in the Pediatric Intensive Care Unit. Large Customizable Interactive Monitor (LCIM). Appl Clin Inform. 2016 Jul 20;7(3):682-92. PMCID: PMC5052542
35. Flynn KE, Lin L, Bruner DW, Cyranowski JM, Hahn EA, Jeffery DD, Reese JB, Reeve BB, Shelby RA, Weinfurt KP. Sexual Satisfaction and the Importance of Sexual Health to Quality of Life Throughout the Life Course of U.S. Adults. J Sex Med. 2016 Nov;13(11):1642-1650. PMCID: PMC5075511
36. Holden RJ, Asan O, Wozniak EM, Flynn KE, Scanlon MC. Nurses' perceptions, acceptance, and use of a novel in-room pediatric ICU technology: testing an expanded technology acceptance model. BMC Med Inform Decis Mak. 2016 Nov 15;16(1):145. PMCID: PMC5109818
37. Flynn KE, Carter J, Lin L, Lindau ST, Jeffery DD, Reese JB, Schlosser BJ, Weinfurt KP. Assessment of vulvar discomfort with sexual activity among women in the United States. Am J Obstet Gynecol. 2017 Apr;216(4):391.e1-391.e8. PMCID: PMC5376372
38. Duthie EA, Cooper A, Davis JB, Sandlow J, Schoyer KD, Strawn E, Flynn KE. Priorities for family building among patients and partners seeking treatment for infertility. Reprod Health. 2017 Apr 05;14(1):52. PMCID: PMC5382407
39. Flynn KE, Lin L, Weinfurt KP. Sexual function and satisfaction among heterosexual and sexual minority U.S. adults: A cross-sectional survey. PLoS One. 2017;12(4):e0174981. PMCID: PMC5389646
40. May M, Brousseau DC, Nelson DA, Flynn KE, Wolf MS, Lepley B, Morrison AK. Why Parents Seek Care for Acute Illness in the Clinic or the ED: The Role of Health Literacy. Acad Pediatr. 2018 Apr;18(3):289-296. PMCID: PMC5732897
41. Griffith JW, Messersmith EE, Gillespie BW, Wiseman JB, Flynn KE, Kirkali Z, Kusek JW, Bavendam T, Cella D, Kreder KJ, Nero JJ, Corona ME, Bradley CS, Kenton KS, Helfand BT, Merion RM, Weinfurt KP, LURN Study Group. Reasons for Seeking Clinical Care for Lower Urinary Tract Symptoms: A Mixed Methods Study. J Urol. 2018 Feb;199(2):528-535. PMCID: PMC5775934
42. Duthie EA, Cooper A, Davis JB, Schoyer KD, Sandlow J, Strawn EY, Flynn KE. A conceptual framework for patient-centered fertility treatment. Reprod Health. 2017 Sep 07;14(1):114. PMCID: PMC5590184
43. Shaw BE, Brazauskas R, Millard HR, Fonstad R, Flynn KE, Abernethy A, Vogel J, Petroske C, Mattila D, Drexler R, Lee SJ, Horowitz MM, Rizzo JD. Centralized patient-reported outcome data collection in transplantation is feasible and clinically meaningful. Cancer. 2017 Dec 01;123(23):4687-4700. PMCID: PMC5693638
44. DeLamater JD, Weinfurt KP, Flynn KE. Patients' Conceptions of Terms Related to Sexual Interest, Desire, and Arousal. J Sex Med. 2017 Nov;14(11):1327-1335. PMCID: PMC5675768
45. Kingsberg SA, Althof S, Simon JA, Bradford A, Bitzer J, Carvalho J, Flynn KE, Nappi RE, Reese JB, Rezaee RL, Schover L, Shifrin JL. Female Sexual Dysfunction-Medical and Psychological Treatments, Committee 14. J Sex Med. 2017 Dec;14(12):1463-1491.
46. D'Souza A, Millard H, Knight J, Brazauskas R, Lee SJ, Flynn KE, Rizzo JD, Shaw BE. Prevalence of self-reported sleep dysfunction before allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2018 Aug;53(8):1079-1082. PMCID: PMC6098949
47. Atallah E, Schiffer CA, Weinfurt KP, Zhang MJ, Radich JP, Oehler VG, Pinilla-Ibarz J, Deininger MWN, Lin L, Larson RA, Mauro MJ, Moore JO, Ritchie EK, Shah NP, Silver RT, Wadleigh M, Cortes J, Thompson J, Guhl J, Horowitz MM, Flynn KE. Design and rationale for the life after stopping tyrosine kinase inhibitors (LAST) study, a prospective, single-group longitudinal study in patients with chronic myeloid leukemia. BMC Cancer. 2018 Apr 02;18(1):359. PMCID: PMC5879565
48. Eluri S, Cross RK, Martin C, Weinfurt KP, Flynn KE, Long MD, Chen W, Anton K, Sandler RS, Kappelman MD. Inflammatory Bowel Diseases Can Adversely Impact Domains of Sexual Function Such as Satisfaction with Sex Life. Dig Dis Sci. 2018 Jun;63(6):1572-1582. PMCID: PMC5955825
49. Erker C, Yan K, Zhang L, Bingen K, Flynn KE, Panepinto J. Impact of pediatric cancer on family relationships. Cancer Med. 2018 May;7(5):1680-1688. PMCID: PMC5943435
50. Wright NL, Flynn KE, Brazauskas R, Hari P, D'Souza A. Patient-reported distress is prevalent in systemic light chain (AL) amyloidosis but not determined by severity of disease. Amyloid. 2018 Jun;25(2):129-134.
51. Eluri S, Cross RK, Martin C, Weinfurt KP, Flynn KE, Long MD, Chen W, Anton K, Sandler RS, Kappelman MD. Correction to: Inflammatory Bowel Diseases Can Adversely Impact Domains of Sexual Function Such as Satisfaction with Sex Life. Dig Dis Sci. 2018 Oct;63(10):2816.
52. Ljungman L, Ahlgren J, Petersson LM, Flynn KE, Weinfurt K, Gorman JR, Wettergren L, Lampic C. Sexual dysfunction and reproductive concerns in young women with breast cancer: Type, prevalence, and predictors of problems. Psychooncology. 2018 Dec;27(12):2770-2777. PMCID: PMC6585728
53. Reeve BB, Wang M, Weinfurt K, Flynn KE, Usinger DS, Chen RC. Psychometric Evaluation of PROMIS Sexual Function and Satisfaction Measures in a Longitudinal Population-Based Cohort of Men With Localized Prostate Cancer. J Sex Med. 2018 Dec;15(12):1792-1810. PMCID: PMC6294460
54. Flynn KE, Kliems H, Saoji N, Svenson J, Cox ED. Content validity of the PROMIS® pediatric family relationships measure for children with chronic illness. Health Qual Life Outcomes. 2018 Oct 19;16(1):203. PMCID: PMC6194608
55. Weinfurt KP, Griffith JW, Flynn KE, Cella D, Bavendam T, Wiseman JB, Andreev VP, Lai HH, Liu AB, Kirkali Z, Cameron AP, Bradley CS, LURN Study Group. The Comprehensive Assessment of Self-Reported Urinary Symptoms: A New Tool for Research on Subtypes of Patients with Lower Urinary Tract Symptoms. J Urol. 2019 Jun;201(6):1177-1183. PMCID: PMC6573020
56. Flynn KE, Myers JM, D'Souza A, Schiffer CA, Thompson JE, Atallah E. Exploring Patient Decision Making Regarding Discontinuation of Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia. Oncologist. 2019 Sep;24(9):1253-1258. PMCID: PMC6738285
57. Asan O, Scanlon MC, Crotty B, Holden RJ, Flynn KE. Parental Perceptions of Displayed Patient Data in a PICU: An Example of Unintentional Empowerment. Pediatr Crit Care Med. 2019 May;20(5):435-441. PMCID: PMC6716150
58. Flynn KE, Mansfield SA, Smith AR, Gillespie BW, Bradley CS, Cella D, Clemens JQ, Helmuth ME, Lai HH, Kirkali Z, Talaty P, Weinfurt KP, LURN Study Group. Can 7 or 30-Day Recall Questions Capture Self-Reported Lower Urinary Tract Symptoms Accurately? J Urol. 2019 Oct;202(4):770-778. PMCID: PMC6905458
59. Flynn KE, Mauro MJ, George G, Hinman A, Baim A, Kota V, Larson RA, Lipton JH, Thompson JE, Wadleigh M, Atallah E. Patients' perspectives on the definition of cure in chronic myeloid leukemia. Leuk Res. 2019 May;80:40-42.
60. Cox ED, Connolly JR, Palta M, Rajamanickam VP, Flynn KE. Reliability and validity of PROMIS® pediatric family relationships short form in children 8-17 years of age with chronic disease. Qual Life Res. 2020 Jan;29(1):191-199. PMCID: PMC6980213
61. Neuner JM, Fergestrom NM, Laud PW, Nattinger AB, Beyer KMM, Flynn KE, Pezzin LE. The association of pharmacy fill synchronization with breast cancer endocrine therapy adherence. Cancer. 2019 Nov 15;125(22):3960-3965. PMCID: PMC7946341
62. Cella D, Smith AR, Griffith JW, Kirkali Z, Flynn KE, Bradley CS, Jelovsek JE, Gillespie BW, Helfand BT, Talaty P, Weinfurt KP, LURN Study Group. A New Brief Clinical Assessment of Lower Urinary Tract Symptoms for Women and Men: LURN SI-10. J Urol. 2020 Jan;203(1):164-170. PMCID: PMC6904437
63. D'Souza A, Hari P, Pasquini M, Jacobsen K, Flynn KE. Baseline patient-reported outcomes in light-chain amyloidosis patients enrolled on an interventional clinical trial. Amyloid. 2019;26(sup1):87-88. PMCID: PMC7108667
64. Cusatis R, Fergestrom N, Cooper A, Schoyer KD, Kruper A, Sandlow J, Strawn E, Flynn KE. Too much time? Time use and fertility-specific quality of life among men and women seeking specialty care for infertility. BMC Psychol. 2019 Jul 09;7(1):45. PMCID: PMC6617689
65. Ljungman L, Eriksson LE, Flynn KE, Gorman JR, Ståhl O, Weinfurt K, Wiklander M, Lampic C, Wettergren L. Sexual Dysfunction and Reproductive Concerns in Young Men Diagnosed With Testicular Cancer: An Observational Study. J Sex Med. 2019 Jul;16(7):1049-1059.
66. Cella D, Smith AR, Griffith JW, Flynn KE, Bradley CS, Gillespie BW, Kirkali Z, Talaty P, Jelovsek JE, Helfand BT, Weinfurt KP, LURN Study Group. A new outcome measure for LUTS: Symptoms of Lower Urinary Tract Dysfunction Research Network Symptom Index-29 (LURN SI-29) questionnaire. Neurourol Urodyn. 2019 Aug;38(6):1751-1759. PMCID: PMC6660359
67. Flynn KE, Whicker D, Lin L, Cusatis R, Nyitray A, Weinfurt KP. Sexual Orientation and Patient-Provider Communication About Sexual Problems or Concerns Among US Adults. J Gen Intern Med. 2019 Nov;34(11):2505-2511. PMCID: PMC6848742
68. Holt JM, Cusatis R, Asan O, Williams J, Nukuna S, Flynn KE, Moore J, Crotty BH. Incorporating patient-generated contextual data into care: Clinician perspectives using the Consolidated Framework for Implementation Science. Healthc (Amst). 2020 Mar;8(1):100369.
69. Azam L, Meurer J, Nelson D, Asan O, Flynn K, Knudson P, Young S. Cultural and Social Challenges of Diabetes Self-Management Education Through Physicians' Voices. WMJ. 2018 Dec;117(5):219-223.
70. Asan O, Holden RJ, Flynn KE, Murkowski K, Scanlon MC. Providers' assessment of a novel interactive health information technology in a pediatric intensive care unit. JAMIA Open. 2018 Jul;1(1):32-41. PMCID: PMC6746319
71. D'Souza A, Flynn K, Chhabra S, Dhakal B, Hamadani M, Jacobsen K, Pasquini M, Weihrauch D, Hari P. Rationale and design of DUAL study: Doxycycline to Upgrade response in light chain (AL) amyloidosis (DUAL): A phase 2 pilot study of a two-pronged approach of prolonged doxycycline with plasma cell-directed therapy in the treatment of AL amyloidosis. Contemp Clin Trials Commun. 2017 Dec;8:33-38. PMCID: PMC5898504
72. Asan O, Flynn KE, Azam L, Scanlon MC. Nurses' perceptions of a novel health information technology: A qualitative study in the pediatric intensive care unit. Int J Hum Comput Interact. 2017;33(4):258-264. PMCID: PMC6782057
73. Yang CC, Weinfurt KP, Merion RM, Kirkali Z, LURN Study Group. Symptoms of Lower Urinary Tract Dysfunction Research Network. J Urol. 2016 Jul;196(1):146-52. PMCID: PMC4914448
74. Cusatis R, Holt JM, Williams J, Nukuna S, Asan O, Flynn KE, Neuner J, Moore J, Makoul G, Crotty BH. The impact of patient-generated contextual data on communication in clinical practice: A qualitative assessment of patient and clinician perspectives. Patient Educ Couns. 2020 Apr;103(4):734-740.
75. Stolley MR, Sheean P, Matthews L, Banerjee A, Visotcky A, Papanek P, Woodley L, Flynn KE. Exploring health behaviors, quality of life, and support needs in African-American prostate cancer survivors: a pilot study to support future interventions. Support Care Cancer. 2020 Jul;28(7):3135-3143.
76. Ruark J, Mullane E, Cleary N, Cordeiro A, Bezerra ED, Wu V, Voutsinas J, Shaw BE, Flynn KE, Lee SJ, Turtle CJ, Maloney DG, Fann JR, Bar M. Patient-Reported Neuropsychiatric Outcomes of Long-Term Survivors after Chimeric Antigen Receptor T Cell Therapy. Biol Blood Marrow Transplant. 2020 Jan;26(1):34-43. PMCID: PMC6951812
77. Amundsen CL, Helmuth ME, Smith AR, DeLancey JOL, Bradley CS, Flynn KE, Kenton KS, Henry Lai H, Cella D, Griffith JW, Andreev VP, Eric Jelovsek J, Liu AB, Kirkali Z, Yang CC. Longitudinal changes in symptom-based female and male LUTS clusters Neurourology and Urodynamics. 2019.
78. Flynn KE, Vanness DJ, Myers JM, D'Souza A, Schiffer CA, Thompson JE, Atallah E. In Reply Oncologist. 2019.
79. D'Souza A, Magnus BE, Myers J, Dispenzieri A, Flynn KE. The use of PROMIS patient-reported outcomes (PROs) to inform light chain (AL) amyloid disease severity at diagnosis. Amyloid. 2020 Jun;27(2):111-118. PMCID: PMC7275879
80. Flynn KE, Vanness DJ, Myers JM, D'Souza A, Schiffer CA, Thompson JE, Atallah E. In Reply. Oncologist. 2020 Apr;25(4):e744-e745. PMCID: PMC7160403
81. Amundsen CL, Helmuth ME, Smith AR, DeLancey JOL, Bradley CS, Flynn KE, Kenton KS, Henry Lai H, Cella D, Griffith JW, Andreev VP, Eric Jelovsek J, Liu AB, Kirkali Z, Yang CC, LURN Study Group. Longitudinal changes in symptom-based female and male LUTS clusters. Neurourol Urodyn. 2020 Jan;39(1):393-402. PMCID: PMC7381999
82. Anguzu R, Cusatis R, Fergestrom N, Cooper A, Schoyer KD, Davis JB, Sandlow J, Flynn KE. Decisional conflict among couples seeking specialty treatment for infertility in the USA: a longitudinal exploratory study. Hum Reprod. 2020 Mar 27;35(3):573-582. PMCID: PMC7105327
83. Cusatis RN, Tecca HR, D'Souza A, Shaw BE, Flynn KE. Prevalence of decisional regret among patients who underwent allogeneic hematopoietic stem cell transplantation and associations with quality of life and clinical outcomes. Cancer. 2020 Jun 01;126(11):2679-2686. PMCID: PMC7220834
84. Rau NM, Hasan K, Ahamed SI, Asan O, Flynn KE, Basir MA. Designing a tablet-based prematurity education app for parents hospitalized for preterm birth International Journal of Medical Informatics. September 2020;141.
85. D'Souza A, Szabo A, Flynn KE, Dhakal B, Chhabra S, Pasquini MC, Weihrauch D, Hari PN. Adjuvant doxycycline to enhance anti-amyloid effects: Results from the dual phase 2 trial EClinicalMedicine. June 2020;23.
86. Rau NM, Basir MA, Flynn KE. Parental understanding of crucial medical jargon used in prenatal prematurity counseling. BMC Med Inform Decis Mak. 2020 Jul 22;20(1):169. PMCID: PMC7376726
87. Rau NM, Hasan K, Ahamed SI, Asan O, Flynn KE, Basir MA. Designing a tablet-based prematurity education app for parents hospitalized for preterm birth. Int J Med Inform. 2020 Sep;141:104200.
88. D'Souza A, Szabo A, Flynn KE, Dhakal B, Chhabra S, Pasquini MC, Weihrauch D, Hari PN. Adjuvant doxycycline to enhance anti-amyloid effects: Results from the dual phase 2 trial. EClinicalMedicine. 2020 Jun;23:100361. PMCID: PMC7280748
89. Agochukwu-Mmonu N, Wiseman JB, Smith AR, Helmuth ME, Sarma AV, Cameron AP, Amundsen CL, Flynn KE, Cella D, Weinfurt KP, Kirkali Z, Clemens JQ. Relationship of symptom severity and bother in individuals seeking care for lower urinary tract symptoms Neurourology and Urodynamics. 2020.
90. Flynn KE, Mansfield SA, Smith AR, Gillespie BW, Bradley CS, Cella D, Helmuth ME, Lai HH, Kirkali Z, Talaty P, Griffith JW, Weinfurt KP. Patient demographic and psychosocial characteristics associated with 30-day recall of self-reported lower urinary tract symptoms Neurourology and Urodynamics. 2020.
91. Holt JM, Cusatis R, Winn A, Asan O, Spanbauer C, Williams JS, Flynn KE, Somai M, Laud P, Crotty BH. The Impact of Previsit Contextual Data Collection on Patient-Provider Communication and Patient Activation: Study Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2020 Sep 23;9(9):e20309. PMCID: PMC7542405
92. Flynn KE, Mansfield SA, Smith AR, Gillespie BW, Bradley CS, Cella D, Helmuth ME, Lai HH, Kirkali Z, Talaty P, Griffith JW, Weinfurt KP, LURN Study Group. Patient demographic and psychosocial characteristics associated with 30-day recall of self-reported lower urinary tract symptoms. Neurourol Urodyn. 2020 Sep;39(7):1939-1948. PMCID: PMC8220594
93. Agochukwu-Mmonu N, Wiseman JB, Smith AR, Helmuth ME, Sarma AV, Cameron AP, Amundsen CL, Flynn KE, Cella D, Weinfurt KP, Kirkali Z, Clemens JQ. Relationship of symptom severity and bother in individuals seeking care for lower urinary tract symptoms. Neurourol Urodyn. 2020 Nov;39(8):2161-2170. PMCID: PMC8327284
94. Ernst A, Flynn KE, Weil EM, Crotty BH, Kamaraju S, Fergestrom N, Neuner J. Aromatase Inhibitor Symptom Management Practices: A Retrospective Study. Clin Breast Cancer. 2021 Feb;21(1):e38-e47. PMCID: PMC8923736
95. Atallah E, Schiffer CA, Radich JP, Weinfurt KP, Zhang MJ, Pinilla-Ibarz J, Kota V, Larson RA, Moore JO, Mauro MJ, Deininger MWN, Thompson JE, Oehler VG, Wadleigh M, Shah NP, Ritchie EK, Silver RT, Cortes J, Lin L, Visotcky A, Baim A, Harrell J, Helton B, Horowitz M, Flynn KE. Assessment of Outcomes After Stopping Tyrosine Kinase Inhibitors Among Patients With Chronic Myeloid Leukemia: A Nonrandomized Clinical Trial. JAMA Oncol. 2021 Jan 01;7(1):42-50. PMCID: PMC7662490
96. D'Souza A, Brazauskas R, Dispenzieri A, Panepinto J, Flynn KE. Changes in patient-reported outcomes in light chain amyloidosis in the first year after diagnosis and relationship to NT-proBNP change. Blood Cancer J. 2021 Feb 01;11(2):29. PMCID: PMC7873213
97. Holt JM, Cusatis R, Winn A, Asan O, Spanbauer C, Williams JS, Flynn KE, Somai M, Talsma A, Laud P, Makoul G, Crotty BH. Impact of Pre-visit Contextual Data Collection on Patient-Physician Communication and Patient Activation: a Randomized Trial. J Gen Intern Med. 2021 Nov;36(11):3321-3329. PMCID: PMC8606508
98. Cox ED, Palta M, Lasarev M, Binder AT, Connolly JR, Flynn KE. Influences of health and environmental deprivation on family relationships among children with chronic disease. Qual Life Res. 2021 May;30(5):1337-1346. PMCID: PMC8076063
99. McDonnell S, Yan K, Kim UO, Flynn KE, Liegl MN, Leuthner SR, McIntosh JJ, Basir MA. Information Order for Periviable Counseling: Does It Make a Difference? J Pediatr. 2021 Aug;235:100-106.e1. PMCID: PMC8316277
100. Schoenbeck KL, Atallah E, Lin L, Weinfurt KP, Cortes J, Deininger MWN, Kota V, Larson RA, Mauro MJ, Oehler VG, Pinilla-Ibarz J, Radich JP, Schiffer CA, Shah NP, Silver RT, Thompson JE, Flynn KE. Patient-Reported Functional Outcomes in Patients With Chronic Myeloid Leukemia After Stopping Tyrosine Kinase Inhibitors. J Natl Cancer Inst. 2022 Jan 11;114(1):160-164. PMCID: PMC8755495
101. Flynn KE, Lin L, Carter J, Baser RE, Goldfarb S, Saban S, Weinfurt KP. Correspondence Between Clinician Ratings of Vulvovaginal Health and Patient-Reported Sexual Function After Cancer. J Sex Med. 2021 Oct;18(10):1768-1774. PMCID: PMC8490328
102. D'Souza A, Myers J, Cusatis R, Dispenzieri A, Finkel M, Panepinto J, Flynn KE. Development of a conceptual model of patient-reported outcomes in light chain amyloidosis: a qualitative study. Qual Life Res. 2022 Apr;31(4):1083-1092. PMCID: PMC8993595
103. Kelly DL, Syrjala K, Taylor M, Rentscher KE, Hashmi S, Wood WA, Jim H, Barata A, Flynn KE, Burns LJ, Shaw BE, Petersdorf E, Yero AC, Emmrich AD, Morris KE, Costanzo ES, Knight JM. Biobehavioral Research and Hematopoietic Stem Cell Transplantation: Expert Review from the Biobehavioral Research Special Interest Group of the American Society for Transplantation and Cellular Therapy. Transplant Cell Ther. 2021 Sep;27(9):747-757. PMCID: PMC8428782
104. Davitt C, Flynn KE, Harrison RK, Pan A, Palatnik A. Current practices in gestational diabetes mellitus diagnosis and management in the United States: survey of maternal-fetal medicine specialists. Am J Obstet Gynecol. 2021 Aug;225(2):203-204.
105. Schoenbeck KL, Flynn KE. Health-Related Quality of Life of Patients with Chronic Myeloid Leukemia as Measured by Patient-Reported Outcomes: Current State and Future Directions Current Hematologic Malignancy Reports. 2021.
106. Balza JS, Cusatis R, McDonnell SM, Basir MA, Flynn KE. Effective questionnaire design: How to use cognitive interviews to refine questionnaire items. J Neonatal Perinatal Med. 2022;15(2):345-349. PMCID: PMC9524256
107. Cusatis R, Flynn KE, Vasu S, Pidala J, Muffly L, Uberti J, Tamari R, Mattila D, Mussetter A, Bruzauskas R, Chen M, Leckrone E, Myers J, Mau LW, Rizzo JD, Saber W, Horowitz M, Lee SJ, Burns LJ, Shaw B. Adding Centralized Electronic Patient-Reported Outcome Data Collection to an Established International Clinical Outcomes Registry. Transplant Cell Ther. 2022 Feb;28(2):112.e1-112.e9. PMCID: PMC8915447
108. Glaser AP, Mansfield S, Smith AR, Helfand BT, Lai HH, Sarma A, Yang CC, Taddeo M, Clemens JQ, Cameron AP, Flynn KE, Andreev V, Fraser MO, Erickson BA, Kirkali Z, Griffith JW, LURN Study Group. Impact of Sleep Disturbance, Physical Function, Depression and Anxiety on Male Lower Urinary Tract Symptoms: Results from the Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN). J Urol. 2022 Jul;208(1):155-163. PMCID: PMC9336513
109. Neuner J, Weil E, Fergestrom N, Stolley M, Kamaraju S, Oxencis C, Winn A, Laud PW, Flynn KE. Feasibility of a pharmacist-led symptom monitoring and management intervention to improve breast cancer endocrine therapy adherence. J Am Pharm Assoc (2003). 2022;62(4):1321-1328.e3.
110. Forrest CB, Schuchard J, Bruno C, Amaral S, Cox ED, Flynn KE, Hinds PS, Huang IC, Kappelman MD, Krishnan JA, Kumar RB, Lai JS, Paller AS, Phipatanakul W, Schanberg LE, Sumino K, Weitzman ER, Reeve BB. Self-Reported Health Outcomes of Children and Youth with 10 Chronic Diseases. J Pediatr. 2022 Jul;246:207-212.e1. PMCID: PMC9232908
111. Amtmann D, Bamer AM, Salem R, McMullen K, Beier M, Flynn KE, Foley FW, Weinfurt KP, Wilkie D, Alschuler KN. Extension and Evaluation of the PROMIS Sexual Function and Satisfaction Measures for Use in Adults Living With Multiple Sclerosis Journal of Sexual Medicine. 2022.
112. D'Souza A, Brazauskas R, Stadtmauer EA, Pasquini MC, Hari P, Bashey A, Callander N, Devine S, Efebera Y, Ganguly S, Gasparetto C, Geller N, Horowitz MM, Koreth J, Landau H, Brunstein C, McCarthy P, Qazilbash MH, Giralt S, Krishnan A, Flynn KE. Trajectories of quality of life recovery and symptom burden after autologous hematopoietic cell transplantation in multiple myeloma. Am J Hematol. 2023 Jan;98(1):140-147. PMCID: PMC9659666
113. Balza JS, Bikomeye JC, Beyer KMM, Rublee C, Flynn KE. Elevated blood lead levels of refugee children in the United States: a systematic review of recent literature (2011-2021). Rev Environ Health. 2023 Jun 27;38(2):361-383.
114. Amtmann D, Bamer AM, Salem R, McMullen K, Beier M, Flynn KE, Foley FW, Weinfurt KP, Wilkie D, Alschuler KN. Extension and Evaluation of the PROMIS Sexual Function and Satisfaction Measures for Use in Adults Living With Multiple Sclerosis. J Sex Med. 2022 May;19(5):719-728.
115. Cusatis R, Balza J, Uttke Z, Kode V, Suelzer E, Shaw BE, Flynn KE. Patient-reported cognitive function among hematopoietic stem cell transplant and cellular therapy patients: a scoping review. Qual Life Res. 2023 Apr;32(4):939-964. PMCID: PMC10259487
116. Flynn KE, Wiseman JB, Helmuth ME, Smith AR, Bradley CS, Cameron AP, Henry Lai H, Kirkali Z, Kreder KJ, Geynisman-Tan J, Merion RM, Weinfurt KP, LURN Study Group. Comparing clinical bladder diaries and recalled patient reports for measuring lower urinary tract symptoms in the symptoms of Lower Urinary Tract Dysfunction Research Network (LURN). Neurourol Urodyn. 2022 Nov;41(8):1711-1721. PMCID: PMC9633398
117. Flynn KE, Atallah E, Lin L, Shah NP, Silver RT, Larson RA, Panilla-Ibarz J, Thompson JE, Oehler VG, Radich JP, Kota V, Mauro MJ, Schiffer CA, Cortes J, Weinfurt KP. Patient- and physician-reported pain after tyrosine kinase inhibitor discontinuation among patients with chronic myeloid leukemia. Haematologica. 2022 Nov 01;107(11):2641-2649. PMCID: PMC9614525
118. Hodge A, Sheean P, O'Connor P, Tyler K, Kerschner A, Williams A, Jensik K, Visotcky A, D'Souza A, Hari P, Dhakal B, Chhabra S, Flynn KE, Hagen P, Stolley M. Exploring health behaviors and the feasibility of a lifestyle intervention for patients with multiple myeloma. Support Care Cancer. 2022 Dec;30(12):9771-9779.
119. Cusatis R, Martens MJ, Nakamura R, Cutler CS, Saber W, Lee SJ, Logan BR, Shaw BE, Gregory A, D'Souza A, Hamilton BK, Horowitz MM, Flynn KE. Health-related quality of life in reduced-intensity hematopoietic cell transplantation based on donor availability in patients aged 50-75 with advanced myelodysplastic syndrome: BMT CTN 1102. Am J Hematol. 2023 Feb;98(2):229-250. PMCID: PMC9839494
120. Reinhard M, Flynn KE, Palatnik A. Patient-reported barriers and facilitators for intermittent pneumatic compression device use on the antepartum unit. J Matern Fetal Neonatal Med. 2022 Dec;35(26):10388-10394.
121. Mason SF, Dasgupta M, Flynn KE, Simpson PM, Singh A. Comparison of CAT and short forms for PROMIS pain and physical health domains in children with sickle cell disease Journal of Patient-Reported Outcomes. December 2023;7(1).
122. Hillis C, Flynn KE, Goldman EH, Moreira-Lucas TS, Visentini J, Dorman S, Ballinger R, Byrnes HF, De Palma A, Barbier V, Machado L, Atallah E. A Survey of Patient Experience in CML: American and Canadian Perspectives. Patient Prefer Adherence. 2023;17:331-347. PMCID: PMC9904222
123. D'Souza A, Szabo A, Akinola I, Finkel M, Flynn KE. A cross-sectional study of patient-reported outcomes and symptom burden using PROMIS and PRO-CTCAE measures in light chain amyloidosis. Qual Life Res. 2023 Jun;32(6):1807-1817. PMCID: PMC10350248
124. Akinola IM, Cusatis R, Pasquini MC, Shaw BE, Bollu V, Dalal A, Tesfaye M, Flynn KE. Multi-Stakeholder Qualitative Interviews to Inform Measurement of Patient Reported Outcomes After CAR-T. Transplant Cell Ther. 2023 Apr;29(4):254.e1-254.e9. PMCID: PMC10369368
125. Arthur E, Flynn K, Jeffery D, Cusatis R. Associations between Relationship Status, Anxiety, Sexual Function, and Sexual Satisfaction in Lesbian, Gay, and Bisexual People International Journal of Sexual Health. 2023.
126. Amtmann D, Bamer AM, Salem R, McMullen K, Beier M, Flynn KE, Foley FW, Weinfurt KP, Wilkie D, Alschuler KN. Extension and Evaluation of the PROMIS Sexual Function and Satisfaction Measures for Use in Adults Living with Multiple Sclerosis. J Sex Med. 2022 May 01;19(5):719-728.
127. Hovén E, Flynn KE, Weinfurt KP, Eriksson LE, Wettergren L. Psychometric evaluation of the Swedish version of the PROMIS Sexual Function and Satisfaction Measures in clinical and nonclinical young adult populations. Sex Med. 2023 Feb;11(1):qfac006. PMCID: PMC10065179
128. Abramsohn EM, Pinkerton EA, Wroblewski K, Anitescu M, Flynn KE, Hazen A, Schumm P, Lindau ST. Breast sensorisexual function: a novel patient-reported outcome measure of sexual sensory functions of the breast. J Sex Med. 2023 Apr 27;20(5):671-683. PMCID: PMC10149380
129. Mason SF, Dasgupta M, Flynn KE, Simpson PM, Singh A. Comparison of CAT and short forms for PROMIS pain and physical health domains in children with sickle cell disease. J Patient Rep Outcomes. 2023 Feb 14;7(1):12. PMCID: PMC9929009
130. Rau NM, Mcintosh JJ, Flynn KE, Szabo A, Ahamed SI, Asan O, Hasan MK, Basir MA. Multimedia tablet or paper handout to supplement counseling during preterm birth hospitalization: a randomized controlled trial. Am J Obstet Gynecol MFM. 2023 Apr;5(4):100875.
131. Flynn KE, Lin L, Carter J, Baser RE, Goldfarb S, Saban S, Weinfurt KP. Correspondence Between Clinician Ratings of Vulvovaginal Health and Patient-Reported Sexual Function After Cancer. J Sex Med. 2021 Oct 01;18(10):1768-1774.
132. Palatnik A, Saffian E, Flynn KE, Pan AY, Yee LM, Basir MA, Cruz M. GAP (gestational diabetes and pharmacotherapy) - study protocol for a randomized controlled, two-arm, single-site trial. Contemp Clin Trials. 2023 Aug;131:107237. PMCID: PMC10527045
133. Flynn KE, McDonnell SM, Brazauskas R, Ahamed SI, McIntosh JJ, Pitt MB, Pizur-Barnekow K, Kim UO, Kruper A, Leuthner SR, Basir MA. Smartphone-Based Video Antenatal Preterm Birth Education: The Preemie Prep for Parents Randomized Clinical Trial. JAMA Pediatr. 2023 Jul 31;177(9):921-9. PMCID: PMC10481234
134. D'Souza A, Szabo A, Akinola I, Finkel M, Flynn KE. Differences in patient-reported outcomes (PROs) by disease severity in light chain (AL) amyloidosis. Eur J Haematol. 2023 Oct;111(4):536-543. PMCID: PMC10530507
135. Balza J, Awoyinka I, Kaeppler C, Cusatis R, Flynn KE. Lead poisoning in refugee children living in the United States: A systematic review of case studies Hygiene and Environmental Health Advances. June 2023;6.
136. McDonnell SM, Flynn KE, McIntosh JJ, Brazauskas R, Kim UO, Ahamed SI, Basir MA. Video Education in Early Pregnancy and Parent Knowledge of Neonatal Resuscitation Options: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2023 Nov 01;6(11):e2344645. PMCID: PMC10682831
137. Cusatis R, Johnson C, Schoyer KD, Tsaih SW, Balza J, Sandlow J, Flynn KE. Decision regret among couples experiencing infertility: a mixed methods longitudinal cohort study. Reprod Health. 2023 Nov 09;20(1):165. PMCID: PMC10633954
138. Luebke MC, Davidson ERW, Crotty BH, Fergestrom N, O'Connor RC, Schmitt E, Winn AN, Flynn KE, Neuner JM. Referral and Prescription Patterns for Female Patients With Urinary Incontinence. Urogynecology (Phila). 2024 May 01;30(5):489-497. PMCID: PMC11002977
139. Shaw BE, Flynn KE, He N, Cusatis R, D'Souza A, Hamilton BK, Horowitz MM, Mattila D, Phelan R, Lee SJ, Brazauskas R. Incorporating patient-reported outcome data into a predictive calculator for allogeneic hematopoietic cell transplantation recipients. Cancer. 2024 May 15;130(10):1826-1835. PMCID: PMC11058023
140. Brazauskas R, Flynn K, Krishnan A, Landau H, Giralt S, Pasquini MC, Stadtmauer EA, D'Souza A. Symptom clusters and their impact on quality of life in multiple myeloma survivors: Secondary analysis of BMT CTN 0702 trial. Br J Haematol. 2024 Apr;204(4):1429-1438. PMCID: PMC11006567
141. D'Souza A, Szabo A, Akinola I, Finkel M, Flynn KE. Development and initial validation of the AL-PROfile patient-reported outcome measure in light chain (AL) amyloidosis. Eur J Haematol. 2024 Jun;112(6):900-909. PMCID: PMC11271248
142. Winn AN, Atallah E, Cortes J, Deininger MWN, Kota V, Larson RA, Moore JO, Mauro MJ, Oehler VG, Pinilla-Ibarz J, Radich JP, Shah NP, Thompson JE, Flynn KE. Estimated Savings After Stopping Tyrosine Kinase Inhibitor Treatment Among Patients With Chronic Myeloid Leukemia. JAMA Netw Open. 2023 Dec 01;6(12):e2347950. PMCID: PMC10728762
143. Balza J, Bikomeye JC, Flynn KE. Effectiveness of educational interventions for the prevention of lead poisoning in children: a systematic review. Rev Environ Health. 2024 Mar 01.
144. Lee AY, Lyons AT, Makris V, Kamaraju S, Stolley MR, Neuner JM, Flynn KE. Adherence to adjuvant endocrine therapy for breast cancer: a qualitative exploration of attribution of symptoms among post-menopausal women. Support Care Cancer. 2024 Apr 02;32(4):265.
145. Flynn KE, Saini L, Kataria A, Jadhav K, Yang D, Wei D. HSR24-139: Patient-Reported Outcome Measures Used in Patients With Chronic Phase-Chronic Myeloid Leukemia: A Systematic Review of the Literature Journal of the National Comprehensive Cancer Network : JNCCN. 5 April 2024;22(25).
146. Akinola I, Flynn KE, Szabo A, Finkel M, D'Souza A. Patient-reported satisfaction with telemedicine in light chain (AL) amyloidosis care. Amyloid. 2024 Sep;31(3):235-237. PMCID: PMC11330728
147. Burek AG, Bumgardner C, Liljestrom T, Porada K, Pan AY, Liegl M, Coon ER, Flynn KE, Ullman AJ, Brousseau DC. Use of central venous access devices outside of the pediatric intensive care units. Pediatr Res. 2024 Jun 27.
148. Cusatis R, Litovich C, Feng Z, Allbee-Johnson M, Kapfhammer M, Mattila D, Akinola I, Phelan R, Broglie L, Auletta JJ, Steinert P, Bolon YT, Akhtar O, Bloomquist J, Chen M, Devine SM, Bupp C, Hamadani M, Hengen M, Jaglowski S, Kaur M, Kuxhausen M, Lee SJ, Moskop A, Page KM, Pasquini MC, Rizzo D, Saber W, Spellman SR, Stefanski HE, Tuschl E, Yusuf R, Zhan K, Flynn KE, Shaw BE. Current Trends and Outcomes in Cellular Therapy Activity in the United States, Including Prospective Patient-Reported Outcomes Data Collection in the Center for International Blood and Marrow Transplant Research Registry. Transplant Cell Ther. 2024 Sep;30(9):917.e1-917.e12. PMCID: PMC11587342
149. McDonnell SM, Flynn KE, Barnekow K, Kim UO, Brazauskas R, Ahamed SI, McIntosh JJ, Pitt MB, Leuthner SR, Kruper A, Basir MA. Black women and the preemie prep for parents (P3) program: Exploratory analysis of a clinical trial PEC Innovation. 15 December 2024;5.
150. Biesboer EA, Al Tannir AH, Maring M, Mantz-Wichman M, Flynn KE, Morris RS, de Moya MA, Murphy PB. Patient Perspectives in the Diagnosis and Treatment of Gallstone Disease: A Qualitative Analysis Journal of Surgical Research. October 2024;302:958-965.
151. Ellison JS, Flynn KE, Sheridan K, Siodlarz S, Antonelli J, Bayne CE, Beck H, Ching C, Dangle PP, Dauw C, Davis C, Hollander K, Lange D, Ouimet K, Ouimet C, Pan AY, Penniston K, Scales CD Jr, Shah N, Spiardi R, Streeper N, Whitmore K, Witt M, Zhang L, Tasian GE. A Patient-Prioritized Research Agenda for Clinical Trials in Kidney Stone Disease. J Urol. 2024 Sep 20:101097JU0000000000004242.
152. Luebke MC, Neuner JM, Balza J, Davidson ERW, Hokanson JA, Marowski S, Corey O'Connor R, Schmitt E, Winn AN, Flynn KE. Developing a urinary incontinence primary care pathway: a mixed methods study. Fam Pract. 2024 Oct 08;41(5):798-806. PMCID: PMC11461143
153. Neuner J, Schmitt E, Winn A, Davidson E, O'Connor RC, Marowski S, Luebke M, Balza J, Attewell M, Flynn KE. Urinary Incontinence Medications: Patient-Initiated Concerns in Primary Care. Urogynecology (Phila). 2024 Jun 21.
 
Books, Chapters, and Reviews
1. Flynn KE, Khan S, Klassen A, Schneiderhan E. “Deliberation and medical decision-making,” 2011. In Cultural Factors in Decision Making and Action, ed. Gavriel Salvendy, Taylor and Francis.
 
Editorials, Letters To Editor, Other
1. Weinfurt KP, Flynn KE. Assessing Patient-Reported Outcomes: A Negotiated Process. J Clin Oncol. 2020 Feb 20;38(6):652-653.
2. Flynn KE. PROM Proposal: Analyzing Proxy Reports of Patient-Reported Outcome Measures. Circ Cardiovasc Qual Outcomes. 2021 Nov;14(11):e008529.
3. Weinfurt KP, Flynn K. Some Clarifications Regarding the PROMIS© SexFS: Commentary on Clements et al. (2023) Archives of Sexual Behavior. 2024.
 
Non-Refereed Journal Publications/Original Papers
1. Flynn KE, Atallah E. Quality of Life and Long-Term Therapy in Patients with Chronic Myeloid Leukemia. Curr Hematol Malig Rep. 2016 Apr;11(2):80-5. PMCID: PMC4860261
2. Narra RK, Flynn KE, Atallah E. Chronic Myeloid Leukemia-the Promise of Tyrosine Kinase Inhibitor Discontinuation. Curr Hematol Malig Rep. 2017 Oct;12(5):415-423. PMCID: PMC6045428
3. Schoenbeck KL, Flynn KE. Health-Related Quality of Life of Patients with Chronic Myeloid Leukemia as Measured by Patient-Reported Outcomes: Current State and Future Directions. Curr Hematol Malig Rep. 2021 Dec;16(6):491-499.
 
Abstracts
1. Kappelman M, Martin C, Weinfurt K, Flynn K, Chen W, Anton K, Cross R, Long M, Sandler R. “Sexual Interest and Satisfaction in an Internet Cohort of Patients with Inflammatory Bowel Diseases: P-70.” 2012. Inflammatory Bowel Diseases. 18: S43-S44.
2. Koontz BF, Flynn KE, Reese JB, Urdeneta AI, Moghanaki D, Porter LS. “Significant Variation in Provider Discussion of Sexual Side Effects with Radiotherapy Patients.” 2012. International Journal of Radiation Oncology* Biology* Physics. 84(3): S210.
3. Moore A, Flynn K, Jeffery J, Hahn EA, Reeve B, Keefe F, Lai, J-S, Weinfurt K. "Patients' Understanding of Common Terms Used in Self-Reported Measures of Sexual Function." Journal of Sexual Medicine. 2012. 9:183.
4. Weinfurt K, Flynn K, Moore A, Lin L, Bruner D, Reese JB, Smith A, Reeve B. "Reasons for Sexual Inactivity: Results from a National Survey." Journal of Sexual Medicine. 2012. 9: 209.
5. Flynn K, Reese JB, Bruner D, Dombeck C, Keefe F, Czajkowski S, Reeve B, Shelby R, Weinfurt K. "Patients' Understanding of Interest, Desire, and Arousal." Journal of Sexual Medicine. 2012. 9: 225.
6. Weinfurt K, Flynn K, Lin L, Bruner D, Dombeck C, Cyranowski J, Jeffery D, Keefe F, Luecht R, Porter L, Reese JB, Reeve B, Smith A, Willse J. "Development and Validation of the PROMIS Sexual Function Measure." Journal of Sexual Medicine. 2012. 9:208.
7. Kociol RD, Flynn KE, Hammill, BG, Heidenreich PA, Piña IL, Lytle BL, Albert NM, Curtis LH, Fonarow GC, Peterson ED, Hernandez AF. “National Survey of Care Processes to Reduce Readmission in Patients Hospitalized for Heart Failure: Factors Associated with Lower Readmission Rates.” Circulation. 2011. 124(21).
8. Weinfurt K, Flynn K. "The PROMIS Sexual Function Measure: Development and Early Validation." Annals of Behavioral Medicine. 2011. 41(1): S146.
9. Weinfurt K, Lin L, Flynn K. "PCV111 Analyzing the Relationship Between Changes in PROs and Clinical Endpoints." Value in Health. 2010. 13(3): A170-A171.
10. Flynn KE, Piña IL, Lin L, Blumenthal JA, Cooper LS, Ellis SJ, Fine LJ, Keteyian SJ, Kitzman DW, Kraus WE, Miller NH, O’Connor CM, Spertus JA, Whellan DJ, Schulman KA, Weinfurt KP. “Effect of Exercise Training on Health-related Quality of Life in Patients with Chronic Heart Failure: An HF-ACTION Substudy.” Circulation. 2008. 118: 2309-2317.
11. Flynn KE, Shelby R, Krystal A, Reeve BB, Mitchell S, Buysse D, Keefe F, Weinfurt KP, the PROMIS Sleep-Wake Functioning Committee. “Sleep/wake Functioning During and Following Cancer.” Sleep. 2008. 31: A298.
12. Flynn KE, Lin L, Ellis SJ, Fine L, Pina I, Roll SK, Russell S. Schulman KA, Spertus J, Whellan D, Weinfurt KP. “Relationships Among The Kansas City Cardiomyopathy Questionnaire and Clinical Measures in Patients with Heart Failure.” Journal of the American College of Cardiology. 2008. 51(10): A269.
13. Fortune-Greeley A, Williams MS, Flynn KE, Weinfurt KP, the PROMIS Sexual Function Committee “Developing a Universal Sexual Function Measure: Lessons Learned From Cognitive Interviews.” Annals of Behavioral Medicine. 2008. 35: S145.
14. Flynn KE, Tzeng J, Jeffery DD, Reeve BB, Weinfurt KP, the PROMIS Sexual Function Committee. “Conceptualizations of Sexual Functioning and Intimacy Among Cancer Sufferers and Survivors.” Psycho-Oncology. 2007. 16(9): S135-S136.
15. Flynn KE, Weinfurt KP, Seils DM, Burnett CB, Schulman KA, Meropol NJ. “Decisional Conflict Among Patients who Accept or Decline Participation in Phase I Oncology Studies.” Psycho-Oncology. 2007. 16(9): S166-S167.
16. Jeffery DD, Reeve BB, Tzeng J, Weinfurt KP, Flynn KE, Keefe FJ, Porter LS, Hahn EA, Cella D, the PROMIS Sexual Function Committee. “The sexual function domain of the NIH PROMIS: Preliminary report.” Psycho-Oncology. 2007. 16(9): S233.
17. Flynn KE, Weinfurt KP, Seils DM, Burnett CB, Schulman KA, Meropol NJ. “Decisional conflict among patients who accept or decline participation in phase I oncology studies.” Journal of General Internal Medicine. 2007. 22:38.
18. Flynn KE, Dombeck C, DeWitt EM, Diener LW, Schulman KA, Weinfurt KP. “Incorporating item banks into clinical trials: investigator perceptions.” Journal of General Internal Medicine. 2007. 22:114.